University of Wisconsin Milwaukee

UWM Digital Commons
Theses and Dissertations
August 2021

Negative Regulation of the Kinase LIN-45 By the E3/E4 Ubiquitin
Ligase UFD-2
Augustin Deniaud
University of Wisconsin-Milwaukee

Follow this and additional works at: https://dc.uwm.edu/etd
Part of the Cell Biology Commons, and the Molecular Biology Commons

Recommended Citation
Deniaud, Augustin, "Negative Regulation of the Kinase LIN-45 By the E3/E4 Ubiquitin Ligase UFD-2"
(2021). Theses and Dissertations. 2771.
https://dc.uwm.edu/etd/2771

This Thesis is brought to you for free and open access by UWM Digital Commons. It has been accepted for
inclusion in Theses and Dissertations by an authorized administrator of UWM Digital Commons. For more
information, please contact scholarlycommunicationteam-group@uwm.edu.

NEGATIVE REGULATION OF THE KINASE LIN-45
BY THE E3/E4 UBIQUITIN LIGASE UFD-2

by
Augustin Deniaud

A Thesis Submitted in
Partial Fulfillment of the
Requirements for the Degree of

Master of Science
in Biological Sciences

at
The University of Wisconsin-Milwaukee
August 2021

ABSTRACT
NEGATIVE REGULATION OF THE KINASE LIN-45 BY THE E3/E4 UBIQUITIN
LIGASE UFD-2
by
Augustin Deniaud

The University of Wisconsin-Milwaukee, 2021
Under the Supervision of Professor Claire de la Cova

The serine/threonine kinase BRAF is a key part of the Ras-Raf-MEK-ERK
pathway, an inducer of cell growth, differentiation, and survival. In humans, activating
mutations, most commonly BRAF(V600E), have been detected in several cancers,
including melanoma and thyroid cancer. In the Caenorhabditis elegans ortholog LIN-45,
the equivalent mutation LIN-45(V627E) results in elevated Raf-MEK-ERK signaling. We
performed an unbiased genetic screen to identify negative regulators of LIN-45(V627E).
Here, we report the identification of the E3/E4 ubiquitin ligase UFD-2, and show it is a
negative regulator of LIN-45 protein activity and levels. Loss of UFD-2 leads to
accumulation of wild-type LIN-45 protein as well as LIN-45(V627E). Based on analysis
of truncations in the LIN-45 protein and mutations in the conserved 14-3-3 sites, we
propose a model where UFD-2-dependent regulation requires binding by 14-3-3
proteins. This contrasts with the previously characterized degradation of LIN-45 by the
E3 ubiquitin ligase SEL-10, which only requires a minimal phospho-degron sequence.
We also identify the AAA ATPase CDC-48.1/2, a known interactor of UFD-2, as a
negative regulator of LIN-45 protein stability. These findings represent a previously
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unrecognized mechanism of Ras-Raf-MEK-ERK regulation and will be the basis of
future investigations of ubiquitin-mediated degradation of Raf.
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CHAPTER 1 - INTRODUCTION
BRAF’s role in melanoma
Melanoma is a malignant tumor developed from melanocytes, typically caused by UV
exposure. It is the deadliest form of skin cancers, accounting for an estimated 100,350
cases and 6,850 deaths in 2020 (Siegel, Miller, & Jemal 2020). Annual treatment costs
are predicted to increase to $1.6 billion by 2030 (Guy et al., 2015).
In humans, mutations in the gene BRAF have been detected in certain cancers,
including 70% of melanomas and 30-50% of thyroid cancers (Mercer et al., 2009).
BRAF is a member of the Raf family of proteins kinases. It is activated by GTP-bound
Ras, and in turn activates the kinases MEK and ERK, referred to here as the Ras-RafMEK-ERK pathway. In particular, the V600E in BRAF causes constitutive activity of the
BRAF protein kinase and accounts for more than 80% of mutations in BRAF (Davies et
al., 2002). This mutation induces similar conformation changes to activating
phosphorylations at T599 and S602, leading to constitutive BRAF activity without the
requirement for upstream pathway activation (Köhler & Brummer 2016).

C. elegans as a model organism
The roundworm Caenorhabditis elegans is a powerful model in which to study
mechanisms of animal development (Kaletta & Hengartner, 2006). Once an egg is laid,
an individual passes through several larval molts, termed L1-L4, before developing into
a fertile adult. Due to its invariant cell lineage and fully characterized cells and tissues,
developmental events occur in the same way in each individual. C. elegans is
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transparent, enabling the use of fluorescent transgenes to characterize gene
expression. Tools for genetic manipulation are already well-characterized, including
robust RNAi screening protocols (Conte et al., 2015) and transgenesis using the
CRISPR/Cas9 system (Dickinson & Goldstein, 2016) or transposon insertion (FrøkjaerJensen et al., 2014). Finally, the C. elegans genome is fully sequenced and conserved,
with approximately 41% of C. elegans genes having human orthologs (Kim et al., 2018).

Ras signaling in C. elegans
Signaling through the Ras-Raf-MEK-ERK signaling pathway in C. elegans has diverse
roles in many cellular processes, such as germline development, organogenesis, axon
outgrowth, and cell fate specification (Sundaram 2013), and is strongly conserved
throughout animal evolution (Fig. 1). Several key portions of Ras signaling were first
identified in C. elegans, including the placement of Ras upstream of Raf (Han et al.,
1993) and the identification of pathway components such as Grb2/SEM-5 (Clark et al.,
1992). Ras signaling is required for proper specification of cell fates in the male spicule,
excretory duct cell, and vulval precursor cells. Hyperactivation of Ras signaling in the
vulval precursor cells causes ectopic vulval development, termed the Muv phenotype
(Ferguson & Horvitz 1985).

Regulation of the Ras-Raf-MEK-ERK pathway
Activation of the Ras-Raf-MEK-ERK pathway can occur due to various stimuli, such as
cellular stress and growth factor reception, notably extracellular growth factor (EGF)
binding to its receptor, the receptor tyrosine kinase (RTK) family member EGFR. The
mechanisms of signal transduction are well conserved; for each factor, we reference
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both human and C. elegans proteins. The C. elegans Ras ortholog LET-60 is part of a
family of small GTPases involved in the transmission of extracellular signals leading to
cell growth and development (Sundaram 2013). Activation of the RTK LET-23 causes
recruitment of the Grb2/SOS(SEM-5/SOS-1) complex and recruitment to the plasma
membrane where LET-60 is localized. The guanine nucleotide exchange factor SOS-1
stimulates the release of GDP from LET-60, promoting formation of its active GTPbound state (Karnoub and Weinberg 2008). In its GTP-bound state, LET-60 recruits the
BRAF ortholog LIN-45 to the plasma membrane (Udell et al., 2011). A phosphorylation
cascade then occurs, where LIN-45 phosphorylates its substrate, the MAPKK family
kinase MEK/MEK-2. MEK-2 phosphorylates its substrate, the MAPK family kinase
ERK/MPK-1, and MPK-1 goes on to phosphorylate a wide range of substrates in the
cytoplasm and nucleus, leading to downstream cellular processes (Yoon & Seger
2006).

Figure 1.1. Conservation of the Ras-Raf-MEK-ERK pathway. Humans have several
orthologs of each protein in the pathway: three Ras orthologs (KRAS, HRAS, NRAS), three
Raf orthologs (ARAF, BRAF, CRAF/RAF1), two MEK orthologs (MEK1, MEK2), and two
ERK orthologs (ERK1, ERK2). In comparison, the pathway in C. elegans is simpler, with
only one ortholog of each: LET-60(Ras), LIN-45(Raf), MEK-2(MEK), and MPK-1(ERK).
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Regulation of BRAF activation is controlled through several steps (Lavoie & Therrien
2015). Inactive BRAF exists in the cytosol in an auto-inhibited state in a complex with
14-3-3 proteins bound to phosphorylated S365 (Muslin et al. 1996). Once Ras is
activated, it binds to BRAF through the Ras-binding domain (RBD) and cysteine-rich
domain (CRD) region, recruiting BRAF to the plasma membrane. This step includes
dephosphorylation of S365, release of the 14-3-3, and relieving of the auto-inhibition
(Dhillon et al. 2002). BRAF is then phosphorylated several times, and finally dimerizes
with the assistance of 14-3-3 proteins (Garnett et al., 2005, Rushworth et al., 2006).
Phosphorylation of T599 and S602 leads to opening of an inhibitory loop in the catalytic
cleft of BRAF and is required for kinase activation. The oncogenic V600E mutation
mimics the phosphorylation of these residues in that it also results in opening of the
inhibitory loop (Kiel et al., 2016).
LIN-45 sequence, regulation, and activity is strongly conserved from C. elegans to
human. Sequence similarity is high (Appendix A), especially in the RBD, CRD, and
kinase domain, which are highly conserved among all Raf family members (Han et al.,
1993). LIN-45 regulation is also conserved, as LET-60 binding, 14-3-3 binding, and
kinase activity were found to be necessary for full LIN-45 function (Hsu et al., 2001).
Activation of LIN-45 through phosphorylation of residues at the activation loop site is
also conserved, as mutations of these residues to phosphomimetic residues was
enough to cause constitutive kinase activity in both worm and human models (Chong,
Lee, & Guan 2001, de la Cova & Greenwald 2012).
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The role of the Ras-Raf-MEK-ERK pathway in vulval development of C. elegans
In C. elegans, the Ras-Raf-MEK-ERK pathway is important in cell fate specification
during vulval development (Shin & Reiner, 2018). The C. elegans vulva arises from six
vulval precursor cells (VPCs) named P3.p-P8.p (Fig. 2). Each VPC can adopt primary,
secondary, or tertiary fate depending on the signaling it receives. During normal
development, the nearby anchor cell (AC) releases epidermal growth factor(EGF),
which activates the Ras-Raf-MEK-ERK pathway in the closest VPC, P6.p. This results
in induction of primary fate in P6.p, which undergoes several cell divisions to develop
into the central structures of the vulva. One substrate of ERK in VPCs is the
transcription factor and repressor Elk1/LIN-1. Phosphorylation of LIN-1 relieves
repression of its target genes and results in transcription of the DSL/Notch ligand LAG-2
(Zhang & Greenwald 2011). LAG-2 then activates the Notch pathway in the adjacent
VPCs P5.p and P7.p, resulting in secondary fate specification in these VPCs and further
cell divisions that lead to development into the side structures of the vulva. Activation of
the Notch pathway also suppresses primary fate specification. VPCs that receive
neither the primary nor secondary fate signals adopt tertiary fate and fuse with the
hypodermis.
The Ras-Raf-MEK-ERK pathway can become hyperactivated through mechanisms
such as mutations that hyperactivate Ras, mutations that hyperactivate Raf, or the loss
of a negative regulator (Schubbert, Shannon & Bollag 2007). Hyperactivation of the
pathway in VPCs results in ectopic primary fate specification and the development of
pseudovulval structures, termed the Muv phenotype. Introduction of a transgene
expressing LIN-45(V627E) only results in a mild Muv phenotype (de la Cova &
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Greenwald, 2012). Loss of negative regulators, including the genes sel-10, gsk-3, and
cdk-2 further described below, enhances the Muv phenotype resulting from LIN45(V627E) (de la Cova & Greenwald, 2012; de la Cova et al., 2020).

Figure 1.2. The patterning of VPC fates and lineages in the development of the C.
elegans vulva. The inductive signal EGF/LIN-3 is released by the anchor cell (AC). The
nearest VPC to the AC, P6.p, receives the signal and activates the Ras-Raf-MEK-ERK
pathway. This activation causes P6.p to adopt primary fate (1°). Activation also causes
expression of the lateral signal, activating the Notch pathway in adjacent VPCs (P5.p
and P7.p). This activation causes these VPCs to adopt secondary fate (2°). Cells which
receive neither signal adopt tertiary fate (3°) and fuse with the hypodermis.
The ubiquitin-proteasome system
The ubiquitin-proteasome system is a major regulator of protein levels through ubiquitinmediated proteolysis. In this system, proteins are modified by the covalent addition of
the small protein ubiquitin. The enzymes that perform this modification are classified
into E1, E2, E3, and E4 ubiquitin ligases (Papaevgeniou & Chondrogianni 2014).
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Ubiquitin is first activated by an E1 category enzyme. Ubiquitin is then passed to an E2
conjugating enzyme. A substrate-specific E3 ligase recruits its target and mediates the
passing of ubiquitin from the E2 to the substrate. Additional ubiquitin peptides are then
added to the present ubiquitin by either E3 or E4 ubiquitin ligases. E3 ligases are
capable of mono- or poly-ubiquitination, but E4 ligases are only capable of polyubiquitination. There exist several classes of E3 and E4 ligases, including U-box domain
proteins, monomeric RING finger proteins, and multisubunit RING finger complexes
(Passmore & Barford 2004).
Once modified with poly-ubiquitin chains, proteins are recognized as substrates for the
26S proteasome, a large cylindrical protein complex that consists of a proteolytic core
and two regulatory complexes. These are responsible for recognition of ubiquitinated
substrates, deubiquitination, and translocation to the core. Upon translocation,
substrates are broken down into short peptide chains by caspase-like, trypsin-like, and
chymotrypsin-like subunits (Jung, Catalgol & Grune 2009).

Regulation of C. elegans LIN-45 through ubiquitination
In addition to its activation cycle, LIN-45 activity in VPCs is also regulated by the
ubiquitin-proteasome system. During the development of VPCs, levels of LIN-45 follow
a specific pattern (Fig. 3). LIN-45 protein is present in all VPCs during the L2 stage.
During L3, LIN-45 is degraded in P6.p. LIN-45 remains expressed in P5.p and P7.p
throughout vulval formation (de la Cova et al., 2020). Because tertiary fate cells fuse
with the large hypodermal cell, levels of LIN-45 become undetectable by fluorescence.
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Figure 1.3. The developmental patterning of LIN-45 protein levels. LIN-45 is first
expressed in all VPCs. During the L3 larval stage, LIN-45 is degraded in P6.p when
SEL-10 recognizes the ERK-mediated phosphorylations of the CPD. Due to the lack of
ERK activity in P5.p and P7.p, LIN-45 remains present in these VPCs. Once P3.p, P4.p,
and P8.p fuse with the hypodermis, LIN-45 diffuses throughout the hypodermis and
becomes undetectable by fluorescence.
SEL-10 is a conserved F-box protein and member of a multiprotein Skp1/Cul1/F-box
(SCF) complex that acts as an E3 ubiquitin ligase. SEL-10 recognizes substrates for
ubiquitination through physical interaction with a phosphorylated degron called the Cdc4
phosphodegron (CPD) (Welcker & Clurman 2008). Loss of function mutations in SEL-10
lead to LIN-45 accumulation in P6.p (de la Cova & Greenwald, 2012). LIN-45 contains a
CPD sequence with a high degree of similarity to other SEL-10 substrates, and
mutations in the CPD also lead to accumulation of LIN-45 in P6.p. In humans, the SEL10 ortholog FBXW7 is required for ubiquitination of BRAF (Yeh et al. 2020).
It is possible that CPD phosphorylation is performed by the kinases GSK-3, CDK-2, and
MPK-1, because loss of any of these kinases results in increased LIN-45 levels in P6.p
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(de la Cova et al., 2020). It is interesting that the downstream kinase MPK-1 regulates
LIN-45 degradation, as this suggests the presence of a negative feedback loop (de la
Cova & Greenwald 2012). This negative feedback loop also exists in humans, as ERK
phosphorylates BRAF at several sites, inhibiting its ability to bind to activated Ras (Ritt
et al. 2020).

The UFD-2 protein network
UBE4B/UFD-2 is an E3/E4 ubiquitin ligase (Hoppe et al., 1999) that has been found to
have roles in regulating ubiquitin-mediated degradation of substrates. In C. elegans,
much of our understanding of UFD-2 enzymatic activity comes from studies of its ability
to ubiquitinate UNC-45 (Hoppe et al., 2004, Hellerschmied et al., 2018). For example,
UFD-2 can act as an E3 to ubiquitinate UNC-45 by itself, but it assembles much longer
chains when its activity is combined with that of its partner E3 ubiquitin ligase
CHIP/CHN-1, thus acting as an E4. UFD-2 was found to selectively ubiquitinate UNC-45
in vitro by binding to its tetratricopeptide repeat (TPR) domain, using the nearby UCS
domain for stabilization of complex formation. The TPR domain of CHN-1 is required for
binding to UFD-2 (Hoppe et al., 2004), indicating that UFD-2 may specifically target its
interacting partners through binding to their TPR domains.
Another protein of note that has been found to directly interact with UFD-2 is
CDC48/p97/VCP (Richly et al., 2005). CDC48 is part of the AAA ATPase family of
proteins and promotes degradation of ubiquitinated proteins. It acts as a segregase,
exerting physical force to pull proteins out of complexes and thus facilitate their
degradation by the proteasome (Baek et al., 2013). CDC48 has two structurally similar
orthologs in C. elegans: CDC-48.1 and CDC-48.2 (Appendix B). CDC-48.1 has been
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found to form a complex with UFD-2 and CHN-1 (Janiesch et al., 2007), and these three
proteins were found to cooperate to regulate UNC-45 levels through ubiquitin-mediated
degradation.
Summary of findings
We hypothesized that negative regulators of the Ras-Raf-MEK-ERK pathway act to
inhibit signaling by the activating mutant LIN-45(V627E). In Chapter 2, we describe our
findings that the E3/E4 ubiquitin ligase UFD-2 is a negative regulator of LIN-45 activity.
We find that UFD-2 is required for LIN-45 protein degradation, and that it also regulates
the activated LIN-45(V627E) form. We find that requirements for UFD-2-mediated LIN45 degradation are different from the mechanisms that direct E3 ubiquitin ligase SEL10-mediated degradation. We also find that the known UFD-2-interacting proteins CDC48.1 and 2 are required for LIN-45 degradation.
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CHAPTER 2 - THE E3/E4 UBIQUITIN LIGASE UFD-2 IS A
NEGATIVE REGULATOR OF THE KINASE LIN-45
Abstract
Melanomas commonly carry a mutation, BRAF(V600E), which activates the kinase
BRAF, part of the Ras-Raf-MEK-ERK pathway. In Caenorhabditis elegans, the
equivalent mutation, LIN-45(V627E), causes increased ERK activation and
developmental defects. Here, we report the identification of the E3/E4 ubiquitin ligase
UFD-2 as a negative regulator of LIN-45 activity. Loss of UFD-2 enhances ectopic
vulval fate signaling phenotypes caused by LIN-45(V627E). We find that loss of UFD-2
causes increased endogenous LIN-45 protein accumulation in vulval precursor cells
(VPCs). Using a VPC-specific LIN-45 reporter to quantify protein levels, we find that
UFD-2 partially contributes to LIN-45 degradation and appears to act in the same
pathway as the E3 ubiquitin ligase SEL-10. In contrast to SEL-10, we found that the
Cdc4 phosphodegron (CPD) region of LIN-45 is not sufficient for regulation by UFD-2.
Analysis of truncated LIN-45 protein reporters revealed that two regions of LIN-45 are
required for regulation by UFD-2. A LIN-45 reporter with mutations at both conserved
14-3-3 binding sites is regulated independently of UFD-2. We propose a model where
14-3-3 binding is required for UFD-2-dependent degradation of LIN-45. We also report
that CDC-48.1/2, a known interactor of UFD-2, is required for degradation of LIN-45.
These findings constitute identification of a previously unrecognized mechanism of LIN45 regulation and indicate that further research is required to identify the requirements
for this regulation.

Introduction
A significant portion of melanomas are derived from benign melanocytic nevi, where
mutations in the genes KRAS and BRAF are frequently found, and a large proportion
carry a single, activating mutation: BRAF(V600E). Furthermore, melanoma growth
requires activation of a kinase cascade downstream of Ras, involving the kinases
BRAF, MEK1/2, and ERK1/2 (Lavoie and Therrien 2015) referred to throughout this
work as Raf-MEK-ERK signaling. Although BRAF(V600E) exhibits constitutive kinase
activity (Davies et al. 2002), detection of increased ERK kinase activity is relatively rare
in the benign nevi samples where the BRAF(V600E) mutation is commonly found
(Houben et al. 2008; Venesio et al. 2008). It is not completely understood what factors
account for this discrepancy (Damsky and Bosenberg 2017). Furthermore, while
melanoma growth can be suppressed by inhibition of Raf kinase activity, in clinical
practice, development of drug resistance and disease relapse occurs frequently (Logue
and Morrison 2012). These observations indicate that truly effective treatments for
melanoma will require additional strategies.
In humans the proteins BRAF, RAF1, and ARAF are each Raf family members, while
LIN-45 is the sole Raf ortholog in the nematode Caenorhabditis elegans. The functional
domains and mechanisms of kinase activation are highly similar for each. Raf proteins
consist of a N-terminal region with Ras-binding domain (RBD) and cysteine-rich domain
(CRD), an intermediate “hinge” region, and a C-terminal kinase domain. When inactive,
Raf is found in a monomeric, “closed” conformation characterized by an auto-inhibitory
interaction between the N-terminal RBD-CRD domains and 14-3-3 proteins bound to the
C-terminal region. Interaction with GTP-bound Ras via the RBD releases Raf from the
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closed conformation and results in its recruitment to the plasma membrane. Further
activation steps include Raf phosphorylation at several sites, culminating in dimerization
and auto-phosphorylation within the kinase activation loop. In its fully activated state,
the Raf kinase domain forms a dimer stabilized by dimerized 14-3-3 proteins bound to
the C-terminal region.
Inactivation of Raf is also highly regulated, involving a variety of post-translational
modifications. Within minutes of Raf-MEK-ERK pathway stimulation, Raf is
phosphorylated at several sites by the downstream kinase ERK, providing a mechanism
of negative feedback (Dougherty et al. 2005; Ritt et al. 2010; Eisenhardt et al. 2016).
ERK-directed phosphorylation within the Raf N-terminal region disrupts its interaction
with Ras, while phosphorylation at the C-terminus disrupts Raf dimerization.
Phosphorylation also occurs in a third cluster located in the hinge region, centered on a
conserved motif termed a Cdc4-phosphodegron (CPD) and recognized by the highly
conserved FBXW7/SEL-10, part of a multi-protein Skp/Cullin/Fbox E3 ubiquitin ligase.
In C. elegans, the CPD and SEL-10 are both required for LIN-45 protein degradation
stimulated by high ERK activity. This ERK-directed degradation appears to be
conserved in human cells, where BRAF protein is poly-ubiquitinated and degraded in a
FBXW7-dependent manner (Saei et al. 2018). Finally, completion of the Raf
activation/inactivation cycle requires dephosphorylation by phosphatases including
PP2A.
In this work, we use C. elegans expressing the constitutively active mutant lin45(V627E) to model BRAF(V600E). We discover that the highly conserved E3/E4
ubiquitin ligase UFD-2 acts to negatively regulate signaling by LIN-45(V627E). As
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expected for a negative regulator, loss of ufd-2 enhances phenotypes resulting from the
hyperactive lin-45(V627E) and suppresses phenotypes caused by partial loss-offunction alleles of lin-45. We show that ufd-2 loss increases the degree of ERK
activation and ectopic cell fate specification in lin-45(V627E)-expressing vulval
precursor cells (VPCs) during larval development. We generated fluorescently-tagged
endogenous and transgene reporters of LIN-45 protein in VPCs, and find that UFD-2 is
required for LIN-45 protein degradation in VPCs where ERK activation is high, and that
it likely acts by promoting the SEL-10-mediated degradation previously described.
However, surprisingly, UFD-2 differs from SEL-10 in its substrate requirements within
LIN-45. While solely the phosphorylated CPD is necessary for regulation by SEL-10, we
find that regulation by UFD-2 requires multiple domains of LIN-45, and specifically that
both conserved 14-3-3-binding sites are critical. We also investigated the roles of
potential UFD-2-interacting proteins, finding that the chaperone-related AAA ATPases
CDC-48.1 and CDC-48.2 are required for LIN-45 protein degradation. As the network of
UFD-2 and CDC-48 proteins are highly conserved, these findings may lead to new
insights in the regulation of human Raf proteins.
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Results
UFD-2 is a negative regulator of LIN-45
To understand cellular mechanisms that modulate signaling by the mutant
BRAF(V600E), we generated C. elegans transgenic strains carrying integrated, singlecopy transgenes expressing the same mutation in the worm Raf ortholog, lin-45(V627E)
(Fig. S1A). A small proportion of adult hermaphrodites carrying lin-45(V627E)
transgenes display a Multivulva (Muv) phenotype (de la Cova, et al. 2020) characteristic
of hyperactive Raf-MEK-ERK signaling; however, the majority are wild-type in
appearance (Fig. 1A). In a forward genetic screen, we isolated a recessive mutant that
displays a strongly penetrant Muv phenotype in combination with lin-45(V627E); this
strain carries a nonsense mutation in ufd-2 (Fig. S1B,C). To confirm the role of ufd-2,
we examined the phenotype of mutants carrying the null allele ufd-2(tm1380) (Hoppe et
al. 2004), which we refer to as ufd-2(0) throughout this work. Although ufd-2(0) mutants
never display a Muv phenotype in the presence of lin-45(+), mutants carrying a lin45(V627E) transgene display a Muv phenotype characterized by several ectopic
pseudovulvae (Fig. 1A).
For analysis of ufd-2 function, we examined covTi106, a lin-45(V627E) transgene that
causes a Muv phenotype in approximately 14% of adult hermaphrodites (Fig. 1B). In
ufd-2(0) mutants, the frequency of Muv phenotype is significantly enhanced, affecting
76% of adults. The Muv phenotype is reverted by the introduction of a single-copy
transgene expressing wild-type ufd-2(+) specifically in VPCs (Fig. 1B), confirming that
UFD-2 acts to prevent the Muv phenotype resulting from lin-45(V627E). Furthermore,
the requirement for UFD-2 activity is likely cell-autonomous to VPCs.
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UFD-2 is the sole C. elegans ortholog of human UBE4B, a U-box protein thought to
have E3 and E4 ubiquitin ligase activities and to catalyze the poly-ubiquitin chain
formation that target substrates for proteasome-mediated degradation (Hatakeyama
and Nakayama 2003; Hellerschmied et al. 2018). Our discovery of UFD-2 as a factor
that represses the Muv phenotype resulting from lin-45(V627E) prompted us to
investigate how its role relates to another E3 ubiquitin ligase, SEL-10. We previously
showed that SEL-10 promotes LIN-45 protein degradation and that its recognition of
LIN-45 is mediated by a conserved Cdc4-phosphodegron (CPD) (de la Cova and
Greenwald 2012). As previously reported, the Muv phenotype resulting from lin45(V627E) was significantly enhanced in the null mutant sel-10(ok1632), referred to
throughout as sel-10(0) (Fig. 1B). To determine whether UFD-2 and SEL-10 act in the
same or parallel pathways to influence the Muv phenotype, we examined the phenotype
of ufd-2(0); sel-10(0) double mutants. In animals lacking both ufd-2 and sel-10, the
penetrance and expressivity of the Muv phenotype was significantly increased
compared to either single mutant (Fig. 1B). The additive effect observed suggests that
UFD-2 and SEL-10 act in parallel processes.
If UFD-2 regulates LIN-45 activity, then loss of ufd-2 may suppress phenotypes
resulting from reduced LIN-45 activity. Two hypomorphic alleles of lin-45 were
examined; both alter the LIN-45 Ras-binding-domain (RBD) and result in partial loss of
function and a partially-penetrant Rod-like larval lethal phenotype caused by failure to
specify the duct cell during embryogenesis (Hsu et al. 2002; Abdus-Saboor et al. 2011)
(Fig. 1C). We found that loss of ufd-2 alone did not cause larval lethality. Compared to
either lin-45 hypomorphic mutant alone, the double ufd-2(0); lin-45 mutant displayed a
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moderate but highly significant reduction in larval lethality (Fig. 1C). These results are
consistent with a role for UFD-2 in negatively regulating LIN-45 activity.

Loss of ufd-2 enhances LIN-45(V627E) activity in VPCs
In the C. elegans hermaphrodite, formation of the vulva involves the patterning and cell
fate specification of six epithelial blast cells named P3.p-P8, or vulval precursor cells
(VPCs), reviewed in Shin and Reiner (2018) (Fig. 2A). During L2 and L3 larval stages,
the anchor cell (AC) of the gonad produces LIN-3, an EGF-like inductive signal. Of the
six VPCs, P6.p is located nearest to the AC, and responds to LIN-3 through activation of
EGF receptor (EGFR) and Ras-Raf-MEK-ERK signal transduction. Activation of the C.
elegans ERK ortholog MPK-1 occurs in L2 and L3 stages in P6.p. At the early L3 stage,
MPK-1 activity results in a vulval cell fate termed primary and transcription of
Delta/Serrate/LAG-2 (DSL) ligands. Expression of DSL ligands by P6.p constitutes a
lateral signal, inducing Notch activation and a cell fate termed secondary in the
neighboring P5.p and P7.p cells. MPK-1 and Notch signaling inhibit one another,
resulting in a robust pattern of cell fate specification. VPCs which receive neither the
inductive nor lateral signals adopt tertiary fate and fuse with the hypodermis syncytial
cell hyp7.
Activated ERK directly phosphorylates LIN-1, ortholog of the transcriptional repressor
Elk1, causing derepression of the DSL ligand lag-2 specifically in P6.p (Zhang and
Greenwald 2011). To assess the pattern of primary fate specification in VPCs, we used
arIs222, a lag-2 reporter transgene that drives expression of 2xNLS-tagRFP (Sallee and
Greenwald 2015). Loss of ufd-2 alone does not alter the P6.p-specific expression
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pattern of the lag-2 reporter (Fig. 2B). Expression of activated lin-45(V627E) in all
VPCs causes ectopic lag-2 reporter expression in a significant portion of larvae.
However, lag-2 expression by VPCs that are adjacent to one another is rare, consistent
with previous observations (de la Cova and Greenwald 2012; de la Cova et al. 2020)
and suggesting that LIN-45 signaling and the resulting MPK-1 activation is not strong
enough to overcome lateral signaling by Notch. In larvae expressing lin-45(V627E), loss
of ufd-2 enhances the frequency of ectopic lag-2 reporter expression and the frequency
of ectopic expression by adjacent VPCs (Fig. 2B). These results suggest that UFD-2
acts to reduce the level of MPK-1 activation by LIN-45(V627E) signaling.
We made use of ERK-KTR, an in vivo biosensor developed to monitor ERK activation
(Regot et al. 2014) and adapted for C. elegans (de la Cova et al. 2017) to quantify the
degree of MPK-1 activation in VPCs of ufd-2 mutants. As a Kinase Translocation
Reporter (KTR), ERK-KTR responds to MPK-1 activation through a change in its
nucleo-cytoplasmic localization. In the presence of active MPK-1, the ERK-KTR protein
is phosphorylated and localized to the cytoplasm. Conversely, in the absence of MPK-1,
the ERK-KTR is not phosphorylated and accumulates in the nucleus. ERK-KTR
localization can be expressed as a ratio of cytoplasmic to nuclear signal (Regot et al.
2014), where a higher Cyto/Nuc ratio indicates higher MPK-1 activation (Materials and
Methods).
We examined a VPC-specific ERK-KTR reporter during the early L3 stage, a time when
MPK-1 activation is robust in P6.p (de la Cova et al. 2017), and LIN-45 is subject to
regulated protein degradation (de la Cova et al. 2020). In wild-type larvae, MPK-1
activation is significantly greater in P6.p than in all other VPCs (Fig. 2C). This restriction

18

of MPK-1 activity to P6.p was also observed in ufd-2(0) mutant larvae. MPK-1 activation
in P6.p in ufd-2(0) mutants was moderately, but significantly elevated compared to that
in P6.p in wild type, suggesting that UFD-2 normally dampens MPK-1 activity level.
Expression of lin-45(V627E) does not affect P6.p but causes a significant increase in
MPK-1 activation in P4.p, P5.p, P7.p, and P8.p. In ufd-2(0) mutants expressing lin45(V627E), MPK-1 activation is significantly elevated above levels observed in +; lin45(V627E) controls (Fig. 2C). MPK-1 activation in ufd-2(0); lin-45(V627E) larvae is
particularly high in P4.p and P8.p cells, a pattern similar to the ectopic lag-2 reporter
expression we observed for this genotype (Fig. 2B). Together, the lag-2 reporter and
ERK-KTR results show that when combined with hyperactive lin-45(V627E), loss of ufd2 function results in greater MPK-1 activation. It was more surprising that loss of ufd-2
caused increased MPK-1 activation in P6.p in the presence of lin-45(+). As P6.p is the
only VPC affected, this finding suggests that UFD-2 regulates LIN-45 in cells where
MPK-1 activity is high.

ufd-2 negatively regulates LIN-45 protein stability
UFD-2 has E3/E4 ubiquitin ligase enzymatic activities and a highly conserved role in
promoting protein degradation. To test whether ufd-2 loss impacts the degradation of
endogenous LIN-45 protein, we generated N- and C-terminal GFP knock-in alleles of
lin-45 (Fig. S2A,B). To ensure that VPC patterning and cell fate specification was
completed in the L3 stage larvae we scored, we examined the expression of
endogenous, tagged LIN-45 protein in the descendants of divided VPCs (Materials and
Methods). When tagged at either the C-terminus (Fig. 3A) or N-terminus (Fig. 3B), GFP-
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tagged LIN-45 protein is visible in P5.p and P7.p. Endogenous LIN-45 protein is visibly
lower in P6.p, an expression pattern consistent with previously described transgenic
LIN-45 protein reporters (de la Cova and Greenwald 2012; de la Cova et al. 2020).
Loss of ufd-2 increased the visible protein accumulation of GFP-LIN-45 in P6.p (Fig.
3B). Although partially penetrant, this increased accumulation is seen in 68% of ufd-2(0)
larvae, a significantly higher portion than in wild type (Fig. 3C). Loss of sel-10 also
caused increased protein accumulation of GFP-LIN-45 in P6.p (Fig. S2C), and this
increased accumulation is visible in 100% of sel-10(0) L3 larvae (Fig. 3C). These results
indicate that UFD-2 contributes to LIN-45 protein degradation in P6.p. However, in
contrast to SEL-10, UFD-2 is not absolutely required for this process.
Because loss of ufd-2 causes intermediate and partially penetrant LIN-45 protein
accumulation in P6.p, we also assessed the impact on a LIN-45 protein reporter better
suited for quantitation. When YFP-tagged LIN-45 expression is driven using the VPCspecific lin-31 promoter, protein accumulation is very low in P6.p, despite the activity of
this promoter in six VPCs (de la Cova and Greenwald 2012). Loss of ufd-2 significantly
increases the visibility of YFP-LIN-45 in P6.p (Fig. 3D). To perform our quantitation, we
measured YFP-LIN-45 levels in two contexts: P5.p, a cell where LIN-45 signaling is
inactive, and P6.p, a cell where LIN-45 is activated. In ufd-2(0) mutants, the YFP-LIN-45
level in P5.p was unchanged; however, YFP-LIN-45 in P6.p was significantly increased
compared to wild type (Fig. 3F). These results suggest that UFD-2 acts to promote LIN45 degradation in cells where LIN-45 is activated.
Because loss of sel-10 and ufd-2 are additive in enhancing the Muv phenotype (Fig.
1B), we also tested whether this was true for LIN-45 protein levels. Loss of sel-10
20

caused a significant increase in level of the YFP-LIN-45 reporter in P6.p (Fig. 3F).
However, ufd-2(0); sel-10(0) double mutants did not have greater YFP-LIN-45 levels
compared to sel-10(0) mutants. This non-additive interaction is in contrast to our data
on the Muv phenotype and suggests that with respect to LIN-45 protein levels, sel-10
and ufd-2 act in the same pathway.
We next tested whether ufd-2 impacts levels of the mutant, activated LIN-45(V627E)
protein. When expressed using the lin-31 promoter, fluorescence intensity of mutant
YFP-LIN-45(V627E) is significantly lower than YFP-LIN-45(+) (Fig. 3E). Similar to wildtype YFP-LIN-45(+), the YFP-LIN-45(V627E) mutant is degraded in P6.p, and loss of
ufd-2 significantly elevated the levels observed in P6.p (Fig. 3G). In contrast to YFPLIN-45(+), loss of ufd-2 also elevated levels of YFP-LIN-45(V627E) in P5.p. As our
analysis of the ERK-KTR found that expression of lin-45(V627E) causes elevated MPK1 activation, this observation in P5.p is consistent with a model whereby UFD-2
promotes LIN-45 degradation in any VPC where MPK-1 activity is high.

UFD-2-dependent degradation requires multiple domains of LIN-45
Our findings that UFD-2 and SEL-10 both promote LIN-45 protein degradation prompted
us to compare the sequence requirements in LIN-45 protein for its regulation by each
ubiquitin ligase. SEL-10 recognizes its substrates via an interaction with CPD motifs,
reviewed in Yumimoto and Nakayama (2020). Indeed, a minimal CPD region of LIN-45
that is 64 amino acids in length is sufficient for SEL-10-dependent degradation in P6.p
(de la Cova et al. 2020) (Fig. 4A). We tested whether degradation of the minimal CPD
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region requires ufd-2. In contrast to full-length YFP-LIN-45, a YFP-tagged minimal CPD,
YFP-LIN-45(418-480), is not significantly stabilized in ufd-2(0) mutants (Fig. 4B, C,
compare to Fig. 3F). This observation suggests that full-length LIN-45 protein contains
additional sequences, structural features, or protein-protein interactions outside of the
CPD that are required for UFD-2-dependent regulation.
C. elegans LIN-45 contains several domains that are present in all three human Raf
proteins (Fig. 4A). The N-terminal region of LIN-45 contains two functional domains: a
Ras-binding domain (RBD) known to directly interact with GTP-bound Ras, and a
cysteine-rich domain (CRD) found to have multiple functions. In an inactive Raf
monomer, the CRD interacts with 14-3-3 proteins and stabilizes the auto-inhibited state.
On the other hand, in an activated Raf complex, the CRD is thought to stabilize plasma
membrane association via phospholipid binding. We tested the role of the N-terminus
and RBD-CRD regions of LIN-45 by expressing a truncated form, YFP-LIN-45(288-813).
In contrast to the full-length reporter, this form is degraded in both wild type and ufd-2(0)
mutants (Fig. 4D), suggesting that a functional domain within this region confers
regulation by UFD-2. We next tested the role of Ras-binding by the RBD region.
Mutations in conserved residues Q95 and R118 have been shown to abolish Rasbinding in vitro (Block et al. 1996) and reduce LIN-45 function in vivo (Hsu et al. 2002).
A mutant reporter containing these mutations, YFP-LIN-45(Q95A, R118A), is degraded
in P6.p in wild type, but stabilized in ufd-2(0) mutants (Fig. 4D), suggesting that the
protein interaction with Ras is not required for LIN-45 regulation by UFD-2.
We also tested the roles for LIN-45 sequences found at its C-terminus. The C-terminal
region of LIN-45 contains a highly conserved kinase domain followed by a shorter C-
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terminal “tail” also containing conserved sequences: a 14-3-3 binding site, several sites
phosphorylated by ERK during negative feedback, and sequences that influence Raf
dimerization (Ritt et al. 2010). A truncated reporter, YFP-LIN-45(1-747), lacks all
sequence C-terminal to the kinase domain. In contrast to the full-length reporter, YFPLIN-45(1-747) is degraded in wild type and ufd-2(0) mutants (Fig. 4E), suggesting that
this region is needed for regulation by UFD-2. We also examined a longer form, YFPLIN-45(1-772), that contains the 14-3-3 binding site but lacks the more C-terminal
feedback phosphorylation sites. YFP-LIN-45(1-772) protein is degraded in wild type
larvae but stabilized in ufd-2(0) mutants (Fig. 4E), indicating that its degradation is UFD2-dependent. Because these two C-terminal truncations differ in the presence of a 14-33 binding site (Figs. 4A, 5A), we hypothesized that 14-3-3 binding is required for UFD-2dependent degradation.

LIN-45 regulation by UFD-2 requires the presence of both 14-3-3 binding sites
Like human Raf proteins, LIN-45 contains two highly conserved 14-3-3 binding sites.
Interaction of 14-3-3 proteins with Raf requires phosphorylation of serine residues. In
LIN-45, the C-terminal 14-3-3 site is centered on S756, and a second 14-3-3 site
located in the “hinge region” is centered on S312 (Fig. Figs. 4A, 5A). To understand the
effect of 14-3-3 binding on UFD-2-dependent degradation, we examined alanine
missense mutations at both S312 and S756 sites. In contrast to wild type YFP-LIN45(+), the mutant protein YFP-LIN-45(S312A) accumulates visibly in P6.p (Fig. 5B).
However, degradation of YFP-LIN-45(S312A) remains dependent on ufd-2 (Fig. 5D).
We next examined YFP-LIN-45(S312A, S756A), a mutant form lacking both 14-3-3
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binding sites. Unlike YFP-LIN-45(+) or the single mutant YFP-LIN-45(S312A), this form
was degraded robustly in both wild type and ufd-2(0) mutants, indicating that its
degradation was independent of UFD-2. Taken together with our findings from the Cterminal truncations, these results suggest that degradation of LIN-45 by UFD-2
requires 14-3-3 binding.

An RNAi screen identifies CDC-48.1/2 as a negative regulator of LIN-45 stability
To identify other regulators of LIN-45 protein stability that act with UFD-2, we performed
an RNAi screen of candidate genes, assessing the impact of their depletion on the level
of YFP-LIN-45 in P6.p. The genes tested encode U-box proteins, E1, E2, E3, and E4
ubiquitin ligases, and proteins known to interact in a network including UFD-2, HSP70,
and HSP90 family proteins. To perform this screen, we made use of the VPC-specific
YFP-LIN-45 reporter and scored the presence or absence of YFP-LIN-45 in P6.p
(Materials and Methods).
The chaperone-related AAA ATPase CDC-48/VCP is highly conserved in eukaryotes,
and acts to segregate ubiquitinated protein substrates so that they are targeted to the
proteasome (Richly et al. 2005). In C. elegans, the orthologs CDC-48.1 and CDC-48.2
were shown to associate with UFD-2 (Janiesch et al. 2007), suggesting they may work
in a UFD-2 protein network. Our screen identified both cdc-48.1 and cdc-48.2 as genes
required for protein degradation of YFP-LIN-45 in P6.p. Due to the similarity in their
nucleotide sequence, it is likely that RNAi targeting of one gene also impacts the other.
RNAi depletion of both genes, termed cdc-48.1/2 RNAi, resulted in significantly
increased level of YFP-LIN-45 in P6.p (Fig. 5E).
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We reasoned that if CDC-48 proteins act with UFD-2, they may have the same
substrate requirements that UFD-2 displays in its regulation of LIN-45. To investigate
this possibility, we tested whether cdc-48.1 and cdc-48.2 are required for degradation of
the minimal CPD region reporter YFP-LIN-45(417-480). As expected, cdc-48.1/2 RNAi
did not result in stabilization of the minimal CPD reporter (Fig. 5E). The cdc-48.1/2 RNAi
was capable of stabilizing full-length YFP-LIN-45(+), and sel-10 RNAi stabilized YFPLIN-45(417-480) (Fig. 5E), two positive results suggesting that the failure of cdc-48.1/2
RNAi to impact YFP-LIN-45(417-480) degradation is not explained by ineffective gene
knockdown. cdc-48.1/2 appear to be dispensable for degradation of the minimal CPD,
consistent with their possible role in UFD-2-mediated degradation. We next tested
whether cdc-48.1/2 RNAi impacts the mutant protein YFP-LIN-45(S312A, S756A),
which lacks phosphorylation at 14-3-3 sites. Contrary to our expectations, cdc-48.1/2
RNAi resulted in significantly elevated levels of mutant YFP-LIN-45(S312A, S756A) in
P6.p (Fig. 5E). Taken together, these findings suggest that while UFD-2 may associate
with CDC-48 proteins, the functions of UFD-2 and CDC-48 proteins in promoting LIN-45
degradation differ in their requirement for 14-3-3 binding.

Discussion
In this work, we identified the conserved E3/E4 ubiquitin ligase UFD-2 as a negative
regulator of LIN-45 activity and protein stability. In this Discussion, we (i) propose a
model that UFD-2 promotes LIN-45 protein degradation as part of MPK-1 and SEL-10directed negative feedback, (ii) consider potential mechanisms by which UFD-2 may
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recognize LIN-45 as a substrate, and (iii) consider how our findings offer new insights
into mutations found in human Raf proteins.
Activity-regulated degradation of LIN-45
UFD-2 has a known role in protein quality control, regulating the ubiquitination of
unfolded proteins. For example, an investigation of the best-characterized C. elegans
UFD-2 substrate to date, the myosin chaperone UNC-45, determined that its regulation
by UFD-2 was enhanced when UNC-45 is more unfolded (Hellerschmied et al. 2018).
On the other hand, examination of endogenous UNC-45 revealed that its bulk protein
levels and characteristic downregulation during muscle development were unaffected by
loss of ufd-2. This role for UFD-2 in recognizing unfolded UNC-45 was associated with
activity as a bona fide E3 ubiquitin ligase, sufficient for mono- and poly-ubiquitination of
this substrate.
The observation that UFD-2 targets unfolded substrates does not completely account
for our observations of LIN-45. For example, we found that endogenous LIN-45 protein
accumulation was increased in ufd-2 mutants. LIN-45 was not subject to UFD-2dependent degradation in all VPCs. Rather, regulation by UFD-2 was observed in two
contexts: i) in the presence of lin-45(+), degradation occurred solely in P6.p, and ii) in
animals expressing lin-45(V627E), degradation occurred in other VPCs, such as P5.p.
Interestingly, it did not appear that the activity state of LIN-45 itself confers regulation by
UFD-2, because the strongly hyperactive mutant LIN-45(V627E), the moderately
activated mutant LIN-45(S312A), and the inactive mutant LIN-45(Q95A, R118A) were
all subject to UFD-2-dependent degradation in P6.p. We previously showed that the
kinase MPK-1 and the E3 ubiquitin ligase SEL-10 participate in negative feedback
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resulting in degradation of LIN-45 in P6.p (de la Cova et al. 2020). We propose that
UFD-2 also plays a role in this feedback, promoting LIN-45 degradation specifically in
cells with high MPK-1 activation. Our finding that ufd-2 and sel-10 loss are not additive
with respect to LIN-45 protein levels also suggests that UFD-2 acts in the same process
as SEL-10, further supporting this model.
UFD-2 substrate specificity
In contrast to SEL-10, for which a small CPD region is sufficient for substrate specificity,
we found no single sequence or domain of LIN-45 was sufficient to confer regulation by
UFD-2. The presence of multiple domains, including the N-terminal RBD-CRD region
and the C-terminal 14-3-3 site, were required for UFD-2-dependent degradation. One
possibility to explain this complex requirement is that UFD-2 is required for degradation
when LIN-45 is integrated within a multi-protein quaternary structure. Indeed, cryoelectron microscopy studies have established that Raf can dimerize and Raf complexes
are composed of a large network of proteins, including 14-3-3, KSR, and MEK (Kondo
et al. 2019; Park et al. 2019).
We propose a model where LIN-45 present in multi-protein complex is partially
protected from proteasome targeting; in this form, its efficient degradation requires the
activities of UFD-2 and CDC-48 proteins. The enzymatic activity of CDC-48 as an ATPdependent segregase suggest it may be capable of extracting LIN-45 protein from a
complex quaternary structure, assisting in its proteasome targeting (Baek et al. 2013).
On the other hand, yeast Ufd2p appears to play a role as an adaptor, bridging
interactions between a ubiquitinated protein substrate and Cdc48p (Bohm et al. 2011).
Given the close association of CDC-48 and UFD-2, it was surprising that cdc-48.1 and
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cdc-48.2 were required for the degradation of LIN-45(S312A, S756A), while ufd-2 was
not. However, in yeast, Ufd2p is not the sole adaptor for Cdc48p (Bohm et al. 2011). It
is possible the ability of CDC-48 proteins to work with multiple adaptors may explain the
difference in substrate requirements for UFD-2 and CDC-48.
In C. elegans, UFD-2 interacts with the substrate UNC-45 through a tetratricopeptide
repeat (TPR) motif and a domain characterized by the proteins UNC-45/Cro1/She4p
(UCS) (Hellerschmied et al. 2018). The TPR motif is a 34-amino acid motif found in
repeats; a minimum of three are needed to form a helical structure frequently found in
protein interaction domains (Das et al. 1998). While TPR motifs are not known to be
present in Raf proteins, they may be unrecognized as this motif is highly degenerate.
Alternatively, it is possible that another protein in Raf complexes contains TPR motifs.
For example, HSP90 family members contain TPR sequences and are known to
interact with Raf. Our findings suggest that 14-3-3 binding by LIN-45 is required for
UFD-2-dependent degradation. In this light, it is intriguing that a structural (but not
sequence) similarity has been found between TPR motifs and 14-3-3 proteins (Das et
al. 1998).
New insights into mutations found in human Rafs
Our finds provide new insights into mutations that alter 14-3-3 binding sites in human
Raf proteins. Although uncommon in human BRAF, mutations in human RAF1 that alter
the hinge region 14-3-3 site are observed in some cancers and in patients with Noonan
and LEOPARD syndromes, diseases characterized by elevated Ras-Raf-MEK-ERK
signaling. The mutant RAF1(S259A), which disrupts the serine normally phosphorylated
at this site, causes increased phospho-MEK and phospho-ERK when introduced to
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human cells (Pandit et al. 2007). By observing the analogous mutation in C. elegans,
LIN-45(312A), we find this mutant protein is partially stabilized in P6.p compared to wild
type LIN-45, suggesting it is partly resistant to negative feedback and degradation
directed by MPK-1. Degradation is LIN-45(S312A) remains UFD-2-dependent, and the
mechanism that accounts for its higher accumulation in P6.p is not yet known. To better
understand whether a similar phenotype is seen in RAF1, it will be useful to investigate
the protein degradation of RAF1 and RAF1(259A) in human cells.

Materials and Methods
C. elegans genetics
Strains used in this work are listed in Supplemental Information (Table S1). The
following alleles were obtained from the Caenorhabditis Genetics Center
(https://cgc.umn.edu/). LGII: ufd-2(tm1380). LGIV: lin-45(n2018), lin-45(n2506). LGV:
sel-10(ok1632. The RNAi-sensitized mutant nre-1(hd20) lin-15B(hd126) displays
enhanced RNAi effectiveness in VPCs (Schmitz et al. 2007; Deng et al. 2019). The
transgene arIs222 [lag-2p::2xNLS-tagRFP::unc-54 3′UTR] was previously described
(Sallee and Greenwald 2015; Underwood et al. 2017). The transgene arTi4 [lin31p::YFP-lin-45(417-480)] was previously described (de la Cova et al. 2020).

Plasmids and transgenes used for lin-45 expression in C. elegans
Plasmids for lin-45 reporter transgenes were generated following a method described in
de la Cova and Greenwald (2012). Specifically, the YFP-coding sequence was fused in

29

frame with lin-45 cDNA (Wormbase sequence Y73B6A.5a) to produce a sequence
encoding N-terminally tagged YFP-LIN-45 protein. For expression of YFP-LIN-45 in
VPCs, cDNAs were cloned into pCC395, an expression vector in a miniMos backbone
(Frokjaer-Jensen et al. 2014) that contains a hybrid promoter derived from 5′ and
intronic elements of the lin-31 gene, designated lin-31p (Tan et al. 1998), and a 3′ UTR
derived from the unc-54 gene.

C. elegans alleles made by gene editing
The endogenous GFP knock-in alleles cov37 and cov40 (this work) were generated
through CRISPR/Cas9 methods described in Dickinson et al. (2015); Dickinson and
Goldstein (2016). All guide RNAs used in CRISPR/Cas9 editing were purchased from
Integrated DNA Technologies. Plasmid repair templates containing a Hygromycin Bselectable self-excising cassette were introduced to produce insertions at either the
start or stop codon of lin-45. Allele cov37 contains an insertion at the start of lin-45
isoform Y73B6A.5a, resulting in an N-terminal fusion encoding GFP-3xFLAG-lin-45.
Allele cov40 contains an insertion at the shared stop of all lin-45 isoforms, resulting in a
C-terminal fusion encoding lin-45-3xFLAG-GFP.

C. elegans reporters used to report or alter VPC gene expression
lin-45(V627E). The single-copy integrated transgenes covTi106 and covTi107 (this
work) use the lin-31p elements to drive expression of a mutant cDNA, lin-45(V627E),
followed by the unc-54 3′ UTR.
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VPC-specific ufd-2(+). The single-copy integrated transgene covTi36 (this work) uses
the lin-31p to drive expression of ufd-2 cDNA (Wormbase sequence T05H10.5b),
followed by the unc-54 3’UTR.
lag-2p::2xNLS-tagRFP. The integrated transgene arIs222 (Sallee and Greenwald,
2015) uses 5′ sequences of the lag-2 gene to drive expression of 2xNLS-tagRFP. This
reporter is expressed exclusively in P6.p and daughters at the L3 stage.
lin-31p::YFP-lin-45. The single-copy integrated transgene covTi64 (this work) uses lin31p to drive expression of a full-length YFP-tagged LIN-45 followed by the unc-54 3′
UTR.
lin-31p::YFP-lin-45 mutant forms. All mutant forms of YFP-lin-45 use the same lin-31p
and unc-54 3′ UTR to drive expression of the corresponding transgene. The transgenes
include: arTi4 [yfp-lin-45(417-480)], covTi110 [lin-31p::yfp-lin-45(288-813)], covTi158
[lin-31p::yfp-lin-45(Q95A, R118A)], covTi54 [lin-31p::yfp-lin-45(1-747)], covTi127 [lin31p::yfp-lin-45(1-772)], covTi101 [lin-31p::yfp-lin-45(S312A)], covTi88 [lin-31p::yfp-lin45(S312A,S756A)].

Assessment of Multivulva and L1 lethality phenotypes
To assess the Multivulva phenotype caused by covTi106 [lin-31p::lin-45(V627E)::unc-54
3’UTR], L4 hermaphrodites from uncrowded cultures were picked to fresh plates; adults
were examined ∼24 h later using a dissecting microscope and scored for the presence
of a normal vulva and the number of pseudovulvae. All lin-45(+) and lin-45(V627E)
animals scored for the Multivulva phenotype were grown at 20°C.
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To assess L1 lethality of lin-45 hypomorphic mutants, L4 hermaphrodites were picked
individually and transferred to fresh plates daily. At ~48 h after egg laying, progeny were
examined at the dissecting microscope and scored as live larvae, dead larvae, or
unhatched eggs.

Qualitative scoring of lag-2 reporter expression in VPCs
To score lag-2 reporter expression in the L3 larval stage, 12-16 hour egg collections
were performed and grown at 20°C. At ~2 days after egg collection, live larvae were
mounted on an agarose pad in M9 buffer containing 10 mM levamisole and examined
using a Zeiss Axio Imager microscope. To further refine the developmental stage of
larvae scored, only L3 larvae in which it was evident that VPCs had undergone either
one or two cell divisions were scored. Location of VPC descendants was determined
using DIC optics, and expression of the RFP transgene arIs222 [lag-2p::2xNLS-tagRFP]
was scored on a positive/negative basis. VPC daughters of P3.p, P4.p, and P8.p which
had fused with the hypodermis were scored as negative.

RNAi treatment in C. elegans
Each bacteria strain was grown in liquid culture and spread on NGM plates containing
IPTG inducer, as previously described (Kamath and Ahringer 2003). All strains assayed
carried the mutations nre-1(hd20) lin-15B(hd126), and were synchronized by a standard
bleach/sodium hydroxide protocol to prepare eggs (Stiernagle 2006). Approximately 200
eggs were placed on each RNAi-feeding plate and grown at 20°C. L3 stage larvae were

32

examined after ∼44 h, a time point when larvae of early, mid and late L3 stage were
easily found. Larvae were anesthetized in M9 buffer containing 10 mM levamisole, and
the presence of YFP fluorescence in VPC daughter cells or granddaughter cells was
scored quantitatively as described below.

Imaging of C. elegans
For all imaging, live larvae were mounted on an agarose pad in M9 buffer containing 10
mM levamisole. Images used for quantitation were acquired using a Nikon Ti inverted
microscope equipped with a spinning disk confocal system (Crest Optics) and dual
sCMOS cameras (Teledyne Photometrics).
To assess ERK-KTR localization in VPCs at the early L3 larval stage, animals were
synchronized using 2-hour egg collections, grown at 25°C, and imaged at ~28 hours
after egg collection. Z-stacks of mClover and mCherry were acquired simultaneously at
60x; for all images, exposure time and laser power used for mClover and mCherry were
equal: 500 ms and 25% laser power. For all ERK-KTR experiments, blank images were
acquired using the same parameters.
To quantify YFP-tagged LIN-45 reporter expression in L3 larvae, 12-16 hour egg
collections were performed, grown at 20°C, and imaged at ~2 days after egg collection.
To further refine the developmental stage of larvae scored, only L3 larvae in which it
was evident that VPCs had undergone either one or two cell divisions were scored. Zstacks of YFP were acquired using a 40x objective and the microscope and spinning
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disk system described above; for all images, an exposure time of 500 ms and laser
power of 25% was used.

Image quantitation and analysis
The subcellular localization of the ERK-KTR biosensor was quantified using methods
described in de la Cova, et al. (2017) and the Nikon NIS-Elements software. Briefly,
illumination correction and background subtraction was performed using the blank
images obtained during each experiment. Image segmentation followed by manual
curation was performed in NIS-Elements to create regions of interest (ROIs) for the
nucleus and cytoplasm of VPCs P4.p, P5.p, P6.p, P7.p, and P8.p. (P3.p fuses with the
hyp7 syncytium in approximately half of animals and was not analyzed.) Mean
fluorescence intensity for mClover within the nucleus and cytoplasm was determined for
up to five of the most equatorial Z slices per cell. Data presented is a ratio of the mean
cytoplasmic mClover intensity/mean nuclear mClover intensity, referred to as
“Cyto/Nuc” ratio, per individual cell.
The expression of YFP-tagged LIN-45 protein was quantified using NIS-Elements
software. ROIs for the cytoplasm of daughters or grand-daughters of P5.p, P6.p, and
P7.p were created manually in NIS-Elements. While all other YFP-LIN-45 reporters
were exclusively cytoplasmic, the truncated YFP-LIN-45(417-480) form was both
cytoplasmic and nuclear. For this reason, the nucleus was included in the quantification
of this mutant. Data presented is the mean YFP fluorescence intensity for the most
equatorial Z slice, per set P5.p or P6.p descendants.
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Statistical analysis
For the Muv, L1 lethal, and ectopic lag-2 expression phenotypes, we compared the
frequency of a phenotype in two groups using the Fisher's exact test to calculate a twotailed P-value. For quantitative measurements of ERK-KTR Cyto/Nuc ratio and YFP
reporter fluorescence intensity, we compared the means of multiple groups by
performing a one-way ANOVA followed by multiple pairwise comparisons and
Bonferroni correction to calculate a two-tailed P-value. All statistical analyses were
performed using GraphPad Prism software.
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Figures

Figure 2.1. UFD-2 is a negative regulator of LIN-45 function. A) Top; an adult hermaphrodite carrying
covTi106 expresses the hyperactive lin-45(V627E). Bottom; covTi106 causes a highly penetrant
Multivulva phenotype in the null mutant ufd-2(tm1380). Animals are shown with anterior at left, dorsal at
top. Asterisk indicates location of the vulva; arrowheads indicate locations of pseudovulvae. Scale bar, 50
μm. B) Pseudovulvae displayed by adult hermaphrodites shown as percentage of adults with 1, 2, 3 or
greater numbers of pseudovulvae. lin-45(+) control genotypes were wild-type for ufd-2 (+) or null
(tm1380). Genotypes carrying the lin-45(V627E) transgene covTi106 included: ufd-2(+), ufd-2(tm1380),
the ufd-2 rescue transgene covTi36 [lin-31p::ufd-2(+)] alone or with ufd-2(tm1380), the sel-10(ok1632)
mutant alone or with ufd-2(tm1380). The number of adults scored (n) is indicated in parentheses. A
Fisher’s exact test was used to compare the number of Multivulva adults. *** indicates the p-value
<0.0001. C) Rod-like lethality at the L1 larval stage displayed by mutants lin-45(n2018) and lin-45(n2506),
shown as percentage of larvae. Genotypes scored were either ufd-2(tm1380), or lin-45 hypomorphs, or
ufd-2; lin-45 double mutants. All genotypes for the lin-45(n2018) experiment carried the mutation dpy20(e1282), while all genotypes for the lin-45(n2506) experiment carried the mutation unc-24(e138). The
number of larvae scored (n) is indicated in parentheses. A Fisher’s exact test was used to compare the
number of Rod-like larvae. *** indicates the p-value <0.0001. Complete strain genotypes for B) and C) are
in Supplemental Table S1.
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Figure 2.2 UFD-2 negatively regulates LIN-45 in VPCs. A) VPC fate patterning and cell divisions. In the
L2 larval stage, an inductive signal produced by the anchor cell (AC) activates EGFR and Ras-Raf-MEKERK signaling in P6.p. During the L3 stage, P6.p expresses the LAG-2 lateral signal, activating
Notch/LIN-12 in P5.p and P7.p. B) VPC fates, assessed using the 1° fate reporter arIs222[lag-2p::2xNLStagrfp]. In all panels, rows represent individual larvae, and columns represent different VPCs. Red, lag-2
is expressed; gray, lag-2 is not expressed. The percentage displaying ectopic lag-2 expression (%
Ectopic), or expression in adjacent VPCs (% Adjacent) is indicated. Genotypes with lin-45(+) are in wild
type (n=37) or ufd-2(0) mutants (n=36). The transgene covTi107 was used to express LIN-45(V627E) in
wild type (n=31) or ufd-2(0) mutants (n=36). The Fisher’s Exact Test was performed to compare the
number of larvae with ectopic 1º fate, and the relevant comparison is indicated. C) MPK-1 activation in
individual VPCs was assessed using ERK-KTR localization, where a higher Cyto/Nuc ratio corresponds to
higher MPK-1 activation. Data points represent the mean Cyto/Nuc for individual VPCs. Genotypes with
lin-45(+) are in wild type (n=19) or ufd-2(0) mutants (n=18). covTi107 genotypes expressing LIN45(V627E) are in wild type (n=15) or ufd-2(0) mutants (n=19). To test for significant differences in
Cyto/Nuc ratio, a one-way ANOVA was performed, followed by multiple comparisons and Bonferroni
correction. ***p-value <0.0001; **p-value <0.001.
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Figure 2.3. UFD-2 is required for LIN-45 protein degradation. In all panels, cells produced by VPCs are
shown at the L3 larval stage; descendants of P5.p, P6.p, and P7.p are labeled P5.pxx, P6.pxx, and P7.pxx,
respectively. A) Endogenous LIN-45-GFP, tagged at the C-terminus. B) Endogenous GFP-LIN-45, tagged
at the N-terminus. Shown are wild type (top) and ufd-2(0) mutant (bottom). C) The percentage of larvae
that displayed high levels of endogenous tagged LIN-45 in P6.p descendants, in wild type and ufd-2(0) and
sel-10(0) mutants. The number of larvae scored (n) is indicated. D) The transgenic reporter YFP-LIN-45(+)
in wild type (top) and ufd-2(0) mutants (bottom). E) The mutant YFP-LIN-45(V627E) in wild type (top) and
ufd-2(0) mutants (bottom). F-G) Expression of YFP-tagged LIN-45 reporters in P5.p (green) and P6.p
(purple). To display data from bright and dim cells together, the mean YFP intensities are plotted on a log 10
scale. F) YFP-LIN-45(+) levels in wild type (n=32), ufd-2(0) (n=33), sel-10(0) (n=28), and ufd-2(0); sel-10(0)
(n=30). G) YFP-LIN-45(V627E) levels in wild type (n=36) and ufd-2(0) (n=32). To test for significant
differences in YFP intensity, a one-way ANOVA was performed, followed by multiple comparisons and
Bonferroni correction. *p-value <0.01. ***p-value <0.0001.
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Figure 2.4. UFD-2-dependent degradation requires multiple domains of LIN-45. A) The functional domains
of LIN-45 include the Ras-binding domain (RBD), cysteine-rich domain (CRD), hinge region 14-3-3 site,
Cdc4-phosphodegron (CPD), kinase domain, and C-terminal 14-3-3 site. Wild-type and mutant forms of
YFP-tagged LIN-45 were examined in ufd-2(0) mutants to determine whether their degradation was UFD2 dependent (indicated by +) or independent (indicated by -). B) The YFP-LIN-45(417-480) reporter
contains a minimal CPD region. Shown are YFP-LIN-45(417-480) in wild type (top) and ufd-2(0) mutants
(bottom). The descendants of P5.p, P6.p, P7.p are labeled P5.pxx, P6.pxx, and P7.pxx respectively. C-E)
Expression of YFP-tagged LIN-45 reporters in P6.p. The mean YFP intensity in P6.p is plotted on a log10
scale. C) The truncated YFP-LIN-45(417-480) in wild type (n=31) and ufd-2(0) (n=31). D) The N-terminal
truncated form YFP-LIN-45(288-813) in wild type (n=36) and ufd-2(0) (n=32). A mutant deficient in Rasbinding, YFP-LIN-45(Q95A, R118A), in wild type (n=23) and ufd-2(0) (n=23). E) The C-terminal truncated
form YFP-LIN-45(1-747), in wild type (n=31) and ufd-2(0) (n=19). A truncation that includes the C-terminal
14-3-3 site, YFP-LIN-45(1-772), in wild type (n=35) and ufd-2(0) (n=36). To test for significant differences
in YFP intensity, a one-way ANOVA was performed, followed by multiple comparisons and Bonferroni
correction. ***p-value <0.0001.
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Figure 2.5. UFD-2-dependent degradation requires the 14-3-3 binding sites of LIN-45. A) Alignments of
protein sequence from 14-3-3 binding sites found in the hinge region (top) and C-terminus (bottom) of
human BRAF, ARAF, CRAF, and C. elegans LIN-45. Indicated are the sites of phosphorylation
(asterisks), and endpoints of C-terminal truncated YFP-LIN-45 reporters. B-C) In all panels, cells
produced by VPCs are shown at the L3 larval stage; descendants of P5.p, P6.p, and P7.p are labeled
P5.pxx, P6.pxx, and P7.pxx, respectively. B) The mutant YFP-LIN-45(S312A) reporter in wild type (top)
and ufd-2(0) mutants (bottom). C) The mutant YFP-LIN-45(S312A, S756A) reporter in wild type (top) and
ufd-2(0) mutants (bottom). D) Expression of YFP-tagged LIN-45 reporters in P6.p. The mean YFP
intensity in P6.p is plotted on a log10 scale. Shown are YFP-LIN45(S312A) in wild type (n=42) and ufd2(0) (n=39), and YFP-LIN-45(S312A, S756A) in wild type (n=33) and ufd-2(0) (n=33). E) Expression of
YFP-tagged LIN-45 reporters in P6.p of RNAi-treated L3 stage larvae (Materials and Methods). The mean
YFP intensity in P6.p is plotted on a log10 scale. RNAi-mediated knockdown was used to deplete the
genes cdc-48.1 and cdc-48.2 simultaneously. Shown are the full-length YFP-LIN-45(+) reporter in the
negative control lacZ RNAi (n=33) and cdc-48.1/2 RNAi (n=42), the mutant YFP-LIN-45(S312A, S756A)
reporter in lacZ RNAi (n=32) and cdc-48.1/2 RNAi (n=29), and the truncated minimal CPD YFP-LIN45(417-480) reporter in lacZ RNAi (n=31), cdc-48.1/2 RNAi (n=36), and sel-10 RNAi (n=17). To test for
significant differences in YFP intensity, a one-way ANOVA was performed, followed by multiple
comparisons and Bonferroni correction. ***p-value <0.0001.
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Supplemental Information
Table S1: C. elegans strains used in this work
Strain

Genotype

Figure

N2

wild type isolate

1

PP198

ufd-2(tm1380)

1

MKE339

covTi106 [lin-31p::lin-45(V627E)::unc-54 3'UTR]

1

MKE341

ufd-2(tm1380); covTi106

1

MKE128

covTi36 [lin-31p::ufd-2::unc-54 3'UTR]

1

MKE372

covTi36; covTi106

1

MKE343

covTi106; sel-10(ok1632)

1

MKE392

ufd-2(tm1380); covTi106; sel-10(ok1632)

1

MKE236

ufd-2(tm1380); dpy-20(e1282)

1

WU48

lin-45(n2018) dpy-20(e1282)

1

MKE237

ufd-2(tm1380); lin-45(n2018) dpy-20(e1282)

1

MKE242

ufd-2(tm1380); unc-24(e138)

1

WU49

lin-45(n2506) unc-24(e138)

1

MKE241

ufd-2(tm1380); lin-45(n2506) unc-24(e138)

1

GS7090

arIs222 [lag-2p::2xNLS-tagRFP]

2

MKE111

ufd-2(tm1380); arIs222

2

MKE363

covTi107 [lin-31p::lin-45(V627E)::unc-54 3'UTR]; arIs222

2

MKE365

ufd-2(tm1380); covTi107; arIs222

2

MKE246

covTi15 [lin-31p::ERK-KTR-mClover-T2A-mCherry-his-58::unc54 3'UTR]

2

MKE248

ufd-2(tm1380); covTi15

2

MKE387

covTi15; covTi107

2

MKE388

ufd-2(tm1380); covTi15; covTi107

2
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MKE277

lin-45(cov40)

3

MKE243

lin-45(cov37)

3

MKE267

ufd-2(tm1380); cov37

3

MKE291

cov37; sel-10(ok1632)

3

MKE232

covTi64 [lin-31p::yfp-lin-45::unc-54 3'UTR]

3

MKE234

ufd-2(tm1380); covTi64

3

MKE266

covTi64; sel-10(ok1632)

3

MKE440

ufd-2(tm1380); covTi64; sel-10(ok1632)

3

MKE441

covTi126 [lin31p::yfp-lin-45(V627E)]

3

MKE442

ufd-2(tm1380); covTi126

3

GS7738

arTi4 [lin-31p::yfp-lin-45(417-480)::unc-54 3'UTR]

4

MKE142

ufd-2(tm1380); arTi4

4

MKE382

covTi110 [lin-31p::yfp-lin-45(417-480)::unc-54 3'UTR]

4

MKE384

ufd-2(tm1380); covTi110

4

MKE436

covTi158 [lin-31p::yfp-lin-45(Q95A,R119A)::unc-54 3'UTR]

4

MKE437

ufd-2(tm1380); covTi158

4

MKE181

covTi54 [lin-31p::yfp-lin-45(1-747)::unc-54 3'UTR]

4

MKE192

ufd-2(tm1380); covTi54

4

MKE426

covTi127[lin-31p::yfp-lin-45(1-772)::unc-54 3'UTR]

4

MKE427

ufd-2(tm1380); covTi127

4

MKE310

covTi101 [lin-31p::yfp-lin-45(S312A)::unc-54 3'UTR]

5

MKE312

ufd-2(tm1380); covTi101

5

MKE273

covTi88 [lin-31p::yfp-lin-45(S312A,S756A)::unc-54 3'UTR]

5

MKE335

ufd-2(tm1380); covTi88

5

MKE422

covTi64; nre-1(hd20) lin-15B(hd126)

5

MKE423

covTi88; nre-1(hd20) lin-15B(hd126)

5

GS7825

arTi4; nre-1(hd20) lin-15B(hd126)

5
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Table S2: Gene-specific guide RNAs used for CRISPR/Cas9-mediated gene
editing
All gene-editing strategies made use of the universal Alt-R-Crispr-Cas9 tracrRNA
(Integrated DNA Technologies catalog #1072532), plus a custom gene-specific Alt-R
crRNA targeting the following DNA sequences:
Guide name

20-nucleotide DNA sequence targeted

For allele

Ce.Cas9.LIN-45.1.AJ

5’- TGAAATTAATCCGACTCATT -3’

cov37

crMKE2

5’- AAGGCATACTACAATGTCTA -3’

cov40
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Figure 2.S1. The lin-45(V627E) mutation and identification of a novel ufd-2 mutant. A) Alignment of
protein sequence in the kinase activation loop of human Raf proteins BRAF, ARAF, RAF1, and C.
elegans LIN-45. Indicated are the residues phosphorylated in wild-type Raf proteins (asterisks), and the
valine residue mutated in BRAF(V600E) and LIN-45(V627E) (arrows). B) Diagram of EMS mutagenesis
screen for for mutations that enhance the Multivulva (Muv) phenotype resulting from lin-45(V627E). C)
Linkage data used to map the chromosome location of the recessive mutation cov19. A mutant strain
carrying lin-45(V627E) and cov19 was outcrossed to the Hawaiian wild-type isolate CB4856. Genomic
DNA was pooled from the progeny of at least 50 F2 hermaphrodites displaying a severe Muv phenotype,
presumptive cov19 homozygotes. Reads from whole genome sequencing were analyzed to determine the
percentage composition by Hawaiian SNP sequence versus chromosome location (top panel). Reads
closely linked to the cov19 mutation are expected to consist of very low % Hawaiian SNP sequence. The
normalized linkage score versus chromosome location (bottom panel). Red and gray columns within
Chromosome 2 indicate regions significantly linked to the cov19 Muv phenotype. The location of the ufd-2
gene is also indicated (arrow). D) Diagram of the UFD-2 protein and the ufd-2 gene. The allele cov19 is a
single nucleotide substitution causing a premature stop at codon 472. The deletion allele tm1380 causes
a frameshift and premature stop.
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Figure 2.S2. Endogenous GFP-tagged LIN-45. A) Diagram of the lin-45(cov37) knock-in allele, encoding
N-terminally tagged GFP-3xFLAG-LIN-45. B) Diagram of the lin-45(cov40) knock-in allele, encoding Cterminally tagged LIN-45-3xFLAG-GFP. C) Endogenous GFP-LIN-45, in the sel-10(0) mutant at the L3
larval stage; descendants of P5.p, P6.p, and P7.p are labeled P5.pxx, P6.pxx, and P7.pxx, respectively.
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CHAPTER 3 - DISCUSSION AND CONCLUSIONS
In this work, we have found that UFD-2 participates in degradation of LIN-45 and LIN45(V627E), as loss of UFD-2 results in partial stabilization of LIN-45 protein. In contrast
to regulation by SEL-10, which requires solely a minimal CPD degron sequence, we
found that regulation by UFD-2 requires multiple regions of LIN-45, including a 14-3-3
binding site as well as the N-terminus and C-terminus domains, but loss of UFD-2 does
not stabilize the minimal CPD. One explanation of this novel regulation mechanism is
that UFD-2 requires LIN-45 to be in a certain complex, subcellular compartment, or
have a particular pattern of posttranslational modifications in order to be regulated. In
addition to UFD-2, we have found that CDC-48, a known UFD-2-interacting protein, is
required for LIN-45 protein degradation, since RNAi targeting CDC-48.1 and 2 results in
stabilization of LIN-45 protein.

Our findings raise several questions regarding the regulation of LIN-45 by UFD-2 and
CDC-48: i) is LIN-45 directly ubiquitinated by UFD-2? ii) does UFD-2 act as an E3 or E4
ubiquitin ligase regarding LIN-45? iii) is the role for UFD-2 in regulating Raf protein
degradation conserved in humans? iv) what Raf complex is regulated by UFD-2?

i) Is LIN-45 ubiquitinated by UFD-2?
UFD-2 is known to have E3 and E4 ubiquitin ligase activities. Our experiments establish
that UFD-2 is required for degradation of LIN-45. Based on this observation, we
hypothesize that UFD-2 is responsible for ubiquitination of LIN-45. To test this
possibility, we propose to examine the ubiquitination state of LIN-45 protein in ufd-2
mutants.
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In this work, we have generated an endogenous GFP-FLAG-LIN-45 allele. This allele
can be used in immunoprecipitation of endogenous LIN-45 to determine its
ubiquitination state. To assay LIN-45 ubiquitination, we can harvest worms treated with
a proteasome inhibitor to prevent protein degradation, perform FLAG
immunoprecipitation of LIN-45 with subsequent Western blotting and detection of
ubiquitin with an anti-ubiquitin antibody. Using this method, we may be able to detect
either mono-ubiquitination or poly-ubiquitin chains. If we identify a loss of ubiquitin
chains bound to LIN-45 in a ufd-2(0) mutant, this would indicate that UFD-2 is able to
ubiquitinate LIN-45.

Ubiquitin modifications are added at lysine residues. If we observe that ubiquitination of
LIN-45 requires UFD-2, we could assay where UFD-2 attaches ubiquitin to LIN-45 by
generating CRISPR alleles with mutated lysine residues, or generating these mutants in
a bacterial system.

Immunoprecipitation of endogenous proteins from C. elegans can be technically
challenging. If we are unable to pull down endogenous LIN-45, then an alternative
approach would be to express the components in a bacterial system and assay
ubiquitination activity in vitro, as done in Goh et al. 2008.

ii) Does UFD-2 act as E3 or E4 ubiquitin ligase regarding LIN-45?
UFD-2 has been found to have both E3 and E4 ubiquitin ligase activity. It is still
unknown what type of ubiquitin ligase activity UFD-2 has regarding its regulation of LIN45. One model to explain the regulation of LIN-45 by both SEL-10 and UFD-2 could be
that SEL-10 acts as an E3 to mono-ubiquitinate LIN-45, allowing UFD-2 to act as an E4
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and produce poly-ubiquitin chains. To address this possibility, we can assay sel-10(0) or
double mutant ufd-2(0); sel-10(0) animals using the immunoprecipitation and ubiquitin
detection assay described in the previous section. If sel-10 and ufd-2 both act as E3
ubiquitin ligases responsible for different ubiquitination sites, then we expect to see that
the effect on ubiquitination is additive in the double mutant. Additionally, there may be
differences in the effect of ufd-2 and sel-10 mutants on mono- or poly-ubiquitination.
Mono-ubiquitination can be recognized as one lower molecular weight protein, whereas
poly-ubiquitination produces a characteristic “ladder” of multiple high molecular weight
proteins. If ufd-2 only acts as an E4 ubiquitin ligase adding to a chain initiated by sel-10,
then we expect that ubiquitin chain length in the double mutant will be unchanged from
the sel-10(0) single mutant.

iii) Is the role for UFD-2 in regulating Raf protein degradation conserved in
humans?
Although the Ras-Raf-MEK-ERK pathway is conserved from C. elegans to human, it is
unknown whether the role for UFD-2 in regulating Raf protein degradation is conserved.
Given the high conservation of UFD-2, we hypothesize that the human UFD-2 ortholog
UBE4B also regulates protein degradation of BRAF. To test this possibility, we could
culture human cells, use CRISPR or RNAi to knockdown UBE4B, and assay BRAF
protein degradation using immunoprecipitation methods. This method has previously
been used to show that human BRAF is ubiquitinated in human HEK 293 cells, and that
FBXW7 is required (Saei et al. 2018). Due to this experiment being in vivo, a concern
would be that ubiquitinated BRAF is being directed to the proteasome for degradation.
Delivery of a proteasome inhibitor would be required to stop this activity.
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If UBE4B is able to ubiquitinate BRAF, this would mean that the role of UFD-2 in
regulation of LIN-45 is conserved from worm to human. The role of UBE4B in
oncogenesis and other BRAF(V600E)-derived diseases could then be investigated. For
example, if loss of UBE4B contributes to BRAF(V600E) cancers, then we may find its
mutation occurs more frequently than expected by chance. We can survey available
databases of cancer mutations, such as cBioPortal for Cancer Genomics
(https://www.cbioportal.org/). Another approach would be to assay the effect of UBE4B
knockdown on proliferation phenotypes of normal and melanoma cell lines carrying the
BRAF(V600E) mutation.

iv) What Raf complex is regulated by UFD-2?
Our experiments found that UFD-2 requires a certain complex containing 14-3-3
proteins and the N- and C-terminus domains of LIN-45 for its activity. The exact
complex containing LIN-45 required for UFD-2-mediated degradation is still unknown,
as is the temporal point in LIN-45’s activation cycle at which UFD-2 acts. It is also
unknown if and what other proteins are required to degrade LIN-45 in a UFD-2dependent manner. A co-immunoprecipitation experiment could be used to detect other
proteins present in the LIN-45 complex being regulated, as well as other proteins
required for the degradation activity of UFD-2. We could use CRIPSR/Cas9 to generate
separate epitope tags of endogenous UFD-2, 14-3-3, and CDC-48.1/2, use ELISA to
bind FLAG-tagged LIN-45, and assay which proteins are bound to LIN-45. If UFD-2 is
detected in the presence of 14-3-3, it would indicate that UFD-2 is able to bind a
complex of LIN-45 and 14-3-3. If UFD-2 is unable to bind to LIN-45 in this state, then
this would imply that UFD-2 regulates LIN-45 at a point in its activation cycle where it is
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not bound to 14-3-3. We could also use CRISPR/Cas9 to mutate endogenous LIN-45 to
FLAG-tagged LIN-45(S312A) and LIN-45(S312A,S756A) and assay whether UFD-2 is
able to bind to these mutant alleles. These results would indicate whether UFD-2 can
regulate a form of LIN-45 that is not bound by 14-3-3.

Conclusion
In this work, we find that UFD-2 negatively regulates LIN-45 protein activity and levels
through ubiquitin-mediated degradation. UFD-2-dependent degradation of LIN-45
requires the N- and C-terminus domains of LIN-45. We propose a model where UFD-2dependent regulation of LIN-45 requires the S756 14-3-3 binding site. We also identify
CDC-48.1 and 2, proteins known to interact with UFD-2, as negative regulators of LIN45. These findings raise interesting questions about the role of ubiquitination in
regulation of LIN-45 activity, as well as the relationship between UFD-2 and CDC-48.1
and 2 in this regulation. Further research is required to determine if mutations in UFD-2
contribute to melanoma or other cancers, and what the implications would be for future
therapeutics.

50

REFERENCES
Abdus-Saboor, I., Mancuso, V.P., Murray, J.I., Palozola, K., Norris, C., Hall, D.H.,
Howell, K., Huang, K., and Sundaram, M.V. (2011). Notch and Ras promote
sequential steps of excretory tube development in C. elegans. Development 138,
3545-3555. 10.1242/dev.068148.
Ackermann, L., Schell, M., Pokrzywa, W., Kevei, É., Gartner, A., Schumacher, B., and
Hoppe, T. (2016). E4 ligase-specific ubiquitination hubs coordinate DNA doublestrand-break repair and apoptosis. Nat Struct Mol Biol 23, 995-1002.
10.1038/nsmb.3296.
Baek, G.H., Cheng, H., Choe, V., Bao, X., Shao, J., Luo, S., and Rao, H. (2013). Cdc48:
a swiss army knife of cell biology. J Amino Acids 2013, 183421.
10.1155/2013/183421.
Block, C., Janknecht, R., Herrmann, C., Nassar, N., and Wittinghofer, A. (1996).
Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to
Raf activation in vivo. Nat Struct Biol 3, 244-251. 10.1038/nsb0396-244.
Böhm, S., Lamberti, G., Fernández-Sáiz, V., Stapf, C., and Buchberger, A. (2011).
Cellular functions of Ufd2 and Ufd3 in proteasomal protein degradation depend
on Cdc48 binding. Mol Cell Biol 31, 1528-1539. 10.1128/MCB.00962-10.
Chong, H., Lee, J., and Guan, K.L. (2001). Positive and negative regulation of Raf
kinase activity and function by phosphorylation. EMBO J 20, 3716-3727.
10.1093/emboj/20.14.3716.
Chung, E., and Kondo, M. (2011). Role of Ras/Raf/MEK/ERK signaling in physiological
hematopoiesis and leukemia development. Immunol Res 49, 248-268.
10.1007/s12026-010-8187-5.
Clark, S.G., Stern, M.J., and Horvitz, H.R. (1992). C. elegans cell-signalling gene sem-5
encodes a protein with SH2 and SH3 domains. Nature 356, 340-344.
10.1038/356340a0.
Connell, P., Ballinger, C.A., Jiang, J., Wu, Y., Thompson, L.J., Höhfeld, J., and
Patterson, C. (2001). The co-chaperone CHIP regulates protein triage decisions
mediated by heat-shock proteins. Nat Cell Biol 3, 93-96. 10.1038/35050618.
Conte, D., MacNeil, L.T., Walhout, A.J.M., and Mello, C.C. (2015). RNA Interference in
Caenorhabditis elegans. Curr Protoc Mol Biol 109, 26.23.21-26.23.30.
10.1002/0471142727.mb2603s109.
Damsky, W.E., and Bosenberg, M. (2017). Melanocytic nevi and melanoma: unraveling
a complex relationship. Oncogene 36, 5771-5792. 10.1038/onc.2017.189.

51

Das, A.K., Cohen, P.W., and Barford, D. (1998). The structure of the tetratricopeptide
repeats of protein phosphatase 5: implications for TPR-mediated protein-protein
interactions. EMBO J 17, 1192-1199. 10.1093/emboj/17.5.1192.
Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J.,
Woffendin, H., Garnett, M.J., Bottomley, W., et al. (2002). Mutations of the BRAF
gene in human cancer. Nature 417, 949-954. 10.1038/nature00766.
de la Cova, C., and Greenwald, I. (2012). SEL-10/Fbw7-dependent negative feedback
regulation of LIN-45/Braf signaling in C. elegans via a conserved
phosphodegron. Genes Dev 26, 2524-2535. 10.1101/gad.203703.112.
de la Cova, C., Townley, R., Regot, S., and Greenwald, I. (2017). A Real-Time
Biosensor for ERK Activity Reveals Signaling Dynamics during C. elegans Cell
Fate Specification. Dev Cell 42, 542-553.e544. 10.1016/j.devcel.2017.07.014.
de la Cova, C.C., Townley, R., and Greenwald, I. (2020). Negative feedback by
conserved kinases patterns the degradation of. Development 147.
10.1242/dev.195941.
Deng, Y., Luo, K.L., Shaye, D.D., and Greenwald, I. (2019). A Screen of the Conserved
Kinome for Negative Regulators of LIN-12 Negative Regulatory Region ("NRR")Missense Activity in. G3 (Bethesda) 9, 3567-3574. 10.1534/g3.119.400471.
Dhillon, A.S., Meikle, S., Yazici, Z., Eulitz, M., and Kolch, W. (2002). Regulation of Raf-1
activation and signalling by dephosphorylation. EMBO J 21, 64-71.
10.1093/emboj/21.1.64.
Dickinson, D.J., and Goldstein, B. (2016). CRISPR-Based Methods for Caenorhabditis
elegans Genome Engineering. Genetics 202, 885-901.
10.1534/genetics.115.182162.
Dougherty, M.K., Müller, J., Ritt, D.A., Zhou, M., Zhou, X.Z., Copeland, T.D., Conrads,
T.P., Veenstra, T.D., Lu, K.P., and Morrison, D.K. (2005). Regulation of Raf-1 by
direct feedback phosphorylation. Mol Cell 17, 215-224.
10.1016/j.molcel.2004.11.055.
Eisenhardt, A.E., Sprenger, A., Röring, M., Herr, R., Weinberg, F., Köhler, M., Braun,
S., Orth, J., Diedrich, B., Lanner, U., et al. (2016). Phospho-proteomic analyses
of B-Raf protein complexes reveal new regulatory principles. Oncotarget 7,
26628-26652. 10.18632/oncotarget.8427.
Ferguson, E.L., and Horvitz, H.R. (1985). Identification and characterization of 22 genes
that affect the vulval cell lineages of the nematode Caenorhabditis elegans.
Genetics 110, 17-72.
Frøkjær-Jensen, C., Davis, M.W., Sarov, M., Taylor, J., Flibotte, S., LaBella, M.,
Pozniakovsky, A., Moerman, D.G., and Jorgensen, E.M. (2014). Random and

52

targeted transgene insertion in Caenorhabditis elegans using a modified Mos1
transposon. Nat Methods 11, 529-534. 10.1038/nmeth.2889.
Garnett, M.J., Rana, S., Paterson, H., Barford, D., and Marais, R. (2005). Wild-type and
mutant B-RAF activate C-RAF through distinct mechanisms involving
heterodimerization. Mol Cell 20, 963-969. 10.1016/j.molcel.2005.10.022.
Goh, A.M., Walters, K.J., Elsasser, S., Verma, R., Deshaies, R.J., Finley, D., and
Howley, P.M. (2008). Components of the ubiquitin-proteasome pathway compete
for surfaces on Rad23 family proteins. BMC Biochem 9, 4. 10.1186/1471-2091-94.
Han, M., Golden, A., Han, Y., and Sternberg, P.W. (1993). C. elegans lin-45 raf gene
participates in let-60 ras-stimulated vulval differentiation. Nature 363, 133-140.
10.1038/363133a0.
Hatakeyama, S., and Nakayama, K.I. (2003). U-box proteins as a new family of ubiquitin
ligases. Biochem Biophys Res Commun 302, 635-645. 10.1016/s0006291x(03)00245-6.
Hellerschmied, D., Roessler, M., Lehner, A., Gazda, L., Stejskal, K., Imre, R., Mechtler,
K., Dammermann, A., and Clausen, T. (2018). UFD-2 is an adaptor-assisted E3
ligase targeting unfolded proteins. Nat Commun 9, 484. 10.1038/s41467-01802924-7.
Hoppe, T., Cassata, G., Barral, J.M., Springer, W., Hutagalung, A.H., Epstein, H.F., and
Baumeister, R. (2004). Regulation of the myosin-directed chaperone UNC-45 by
a novel E3/E4-multiubiquitylation complex in C. elegans. Cell 118, 337-349.
10.1016/j.cell.2004.07.014.
Houben, R., Vetter-Kauczok, C.S., Ortmann, S., Rapp, U.R., Broecker, E.B., and
Becker, J.C. (2008). Phospho-ERK staining is a poor indicator of the mutational
status of BRAF and NRAS in human melanoma. J Invest Dermatol 128, 20032012. 10.1038/jid.2008.30.
Hsu, V., Zobel, C.L., Lambie, E.J., Schedl, T., and Kornfeld, K. (2002). Caenorhabditis
elegans lin-45 raf is essential for larval viability, fertility and the induction of vulval
cell fates. Genetics 160, 481-492.
Janiesch, P.C., Kim, J., Mouysset, J., Barikbin, R., Lochmüller, H., Cassata, G., Krause,
S., and Hoppe, T. (2007). The ubiquitin-selective chaperone CDC-48/p97 links
myosin assembly to human myopathy. Nat Cell Biol 9, 379-390.
10.1038/ncb1554.
Jung, T., Catalgol, B., and Grune, T. (2009). The proteasomal system. Mol Aspects Med
30, 191-296. 10.1016/j.mam.2009.04.001.
Kaletta, T., and Hengartner, M.O. (2006). Finding function in novel targets: C. elegans

53

as a model organism. Nat Rev Drug Discov 5, 387-398. 10.1038/nrd2031.
Kamath, R.S., and Ahringer, J. (2003). Genome-wide RNAi screening in Caenorhabditis
elegans. Methods 30, 313-321. 10.1016/s1046-2023(03)00050-1.
Karnoub, A.E., and Weinberg, R.A. (2008). Ras oncogenes: split personalities. Nat Rev
Mol Cell Biol 9, 517-531. 10.1038/nrm2438.
Kiel, C., Benisty, H., Lloréns-Rico, V., and Serrano, L. (2016). The yin-yang of kinase
activation and unfolding explains the peculiarity of Val600 in the activation
segment of BRAF. Elife 5, e12814. 10.7554/eLife.12814.
Kim, W., Underwood, R.S., Greenwald, I., and Shaye, D.D. (2018). OrthoList 2: A New
Comparative Genomic Analysis of Human and. Genetics 210, 445-461.
10.1534/genetics.118.301307.
Koegl, M., Hoppe, T., Schlenker, S., Ulrich, H.D., Mayer, T.U., and Jentsch, S. (1999). A
novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell
96, 635-644. 10.1016/s0092-8674(00)80574-7.
Kondo, Y., Ognjenović, J., Banerjee, S., Karandur, D., Merk, A., Kulhanek, K., Wong,
K., Roose, J.P., Subramaniam, S., and Kuriyan, J. (2019). Cryo-EM structure of a
dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf
kinases. Science 366, 109-115. 10.1126/science.aay0543.
Köhler, M., and Brummer, T. (2016). B-Raf activation loop phosphorylation revisited.
Cell Cycle 15, 1171-1173. 10.1080/15384101.2016.1159111.
Lavoie, H., and Therrien, M. (2015). Regulation of RAF protein kinases in ERK
signalling. Nat Rev Mol Cell Biol 16, 281-298. 10.1038/nrm3979.
Leicht, D.T., Balan, V., Kaplun, A., Singh-Gupta, V., Kaplun, L., Dobson, M., and
Tzivion, G. (2007). Raf kinases: function, regulation and role in human cancer.
Biochim Biophys Acta 1773, 1196-1212. 10.1016/j.bbamcr.2007.05.001.
Logue, J.S., and Morrison, D.K. (2012). Complexity in the signaling network: insights
from the use of targeted inhibitors in cancer therapy. Genes Dev 26, 641-650.
10.1101/gad.186965.112.
Margolis, B., and Skolnik, E.Y. (1994). Activation of Ras by receptor tyrosine kinases. J
Am Soc Nephrol 5, 1288-1299. 10.1681/ASN.V561288.
Mercer, K., Giblett, S., Green, S., Lloyd, D., DaRocha Dias, S., Plumb, M., Marais, R.,
and Pritchard, C. (2005). Expression of endogenous oncogenic V600EB-raf
induces proliferation and developmental defects in mice and transformation of
primary fibroblasts. Cancer Res 65, 11493-11500. 10.1158/0008-5472.CAN-052211.

54

Muslin, A.J., Tanner, J.W., Allen, P.M., and Shaw, A.S. (1996). Interaction of 14-3-3
with signaling proteins is mediated by the recognition of phosphoserine. Cell 84,
889-897. 10.1016/s0092-8674(00)81067-3.
Pandit, B., Sarkozy, A., Pennacchio, L.A., Carta, C., Oishi, K., Martinelli, S., Pogna,
E.A., Schackwitz, W., Ustaszewska, A., Landstrom, A., et al. (2007). Gain-offunction RAF1 mutations cause Noonan and LEOPARD syndromes with
hypertrophic cardiomyopathy. Nat Genet 39, 1007-1012. 10.1038/ng2073.
Papaevgeniou, N., and Chondrogianni, N. (2014). The ubiquitin proteasome system in
Caenorhabditis elegans and its regulation. Redox Biol 2, 333-347.
10.1016/j.redox.2014.01.007.
Park, E., Rawson, S., Li, K., Kim, B.W., Ficarro, S.B., Pino, G.G., Sharif, H., Marto, J.A.,
Jeon, H., and Eck, M.J. (2019). Architecture of autoinhibited and active BRAFMEK1-14-3-3 complexes. Nature 575, 545-550. 10.1038/s41586-019-1660-y.
Passmore, L.A., and Barford, D. (2004). Getting into position: the catalytic mechanisms
of protein ubiquitylation. Biochem J 379, 513-525. 10.1042/BJ20040198.
Regot, S., Hughey, J.J., Bajar, B.T., Carrasco, S., and Covert, M.W. (2014). Highsensitivity measurements of multiple kinase activities in live single cells. Cell 157,
1724-1734. 10.1016/j.cell.2014.04.039.
Richly, H., Rape, M., Braun, S., Rumpf, S., Hoege, C., and Jentsch, S. (2005). A series
of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation
and proteasomal targeting. Cell 120, 73-84. 10.1016/j.cell.2004.11.013.
Ritt, D.A., Monson, D.M., Specht, S.I., and Morrison, D.K. (2010). Impact of feedback
phosphorylation and Raf heterodimerization on normal and mutant B-Raf
signaling. Mol Cell Biol 30, 806-819. 10.1128/MCB.00569-09.
Robert, X., and Gouet, P. (2014). Deciphering key features in protein structures with the
new ENDscript server. Nucleic Acids Res 42, W320-324. 10.1093/nar/gku316.
Rushworth, L.K., Hindley, A.D., O'Neill, E., and Kolch, W. (2006). Regulation and role of
Raf-1/B-Raf heterodimerization. Mol Cell Biol 26, 2262-2272.
10.1128/MCB.26.6.2262-2272.2006.
Saei, A., Palafox, M., Benoukraf, T., Kumari, N., Jaynes, P.W., Iyengar, P.V., MuñozCouselo, E., Nuciforo, P., Cortés, J., Nötzel, C., et al. (2018). Loss of USP28mediated BRAF degradation drives resistance to RAF cancer therapies. J Exp
Med 215, 1913-1928. 10.1084/jem.20171960.
Sallee, M.D., and Greenwald, I. (2015). Dimerization-driven degradation of C. elegans
and human E proteins. Genes Dev 29, 1356-1361. 10.1101/gad.261917.115.
Schmitz, C., Kinge, P., and Hutter, H. (2007). Axon guidance genes identified in a large-

55

scale RNAi screen using the RNAi-hypersensitive Caenorhabditis elegans strain
nre-1(hd20) lin-15b(hd126). Proc Natl Acad Sci U S A 104, 834-839.
10.1073/pnas.0510527104.
Schubbert, S., Shannon, K., and Bollag, G. (2007). Hyperactive Ras in developmental
disorders and cancer. Nat Rev Cancer 7, 295-308. 10.1038/nrc2109.
Shin, H., and Reiner, D.J. (2018). The Signaling Network Controlling C. elegans Vulval
Cell Fate Patterning. J Dev Biol 6. 10.3390/jdb6040030.
Siegel, R.L., Miller, K.D., and Jemal, A. (2020). Cancer statistics, 2020. CA Cancer J
Clin 70, 7-30. 10.3322/caac.21590.
Sternberg, P.W., Golden, A., and Han, M. (1993). Role of a raf proto-oncogene during
Caenorhabditis elegans vulval development. Philos Trans R Soc Lond B Biol Sci
340, 259-265. 10.1098/rstb.1993.0066.
Stiernagle, T. (2006). Maintenance of C. elegans. WormBook, 1-11.
10.1895/wormbook.1.101.1.
Sundaram, M.V. (2013). Canonical RTK-Ras-ERK signaling and related alternative
pathways. WormBook, 1-38. 10.1895/wormbook.1.80.2.
Tan, P.B., Lackner, M.R., and Kim, S.K. (1998). MAP kinase signaling specificity
mediated by the LIN-1 Ets/LIN-31 WH transcription factor complex during C.
elegans vulval induction. Cell 93, 569-580. 10.1016/s0092-8674(00)81186-1.
Udell, C.M., Rajakulendran, T., Sicheri, F., and Therrien, M. (2011). Mechanistic
principles of RAF kinase signaling. Cell Mol Life Sci 68, 553-565.
10.1007/s00018-010-0520-6.
Underwood, R.S., Deng, Y., and Greenwald, I. (2017). Integration of EGFR and LIN12/Notch Signaling by LIN-1/Elk1, the Cdk8 Kinase Module, and SUR-2/Med23
in Vulval Precursor Cell Fate Patterning in. Genetics 207, 1473-1488.
10.1534/genetics.117.300192.
Venesio, T., Chiorino, G., Balsamo, A., Zaccagna, A., Petti, C., Scatolini, M., Pisacane,
A., Sarotto, I., Picciotto, F., and Risio, M. (2008). In melanocytic lesions the
fraction of BRAF V600E alleles is associated with sun exposure but unrelated to
ERK phosphorylation. Mod Pathol 21, 716-726. 10.1038/modpathol.2008.41.
Welcker, M., and Clurman, B.E. (2008). FBW7 ubiquitin ligase: a tumour suppressor at
the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8, 8393. 10.1038/nrc2290.
Yoon, S., and Seger, R. (2006). The extracellular signal-regulated kinase: multiple
substrates regulate diverse cellular functions. Growth Factors 24, 21-44.
10.1080/02699050500284218.

56

Yumimoto, K., and Nakayama, K.I. (2020). Recent insight into the role of FBXW7 as a
tumor suppressor. Semin Cancer Biol 67, 1-15.
10.1016/j.semcancer.2020.02.017.
Zhang, X., and Greenwald, I. (2011). Spatial regulation of lag-2 transcription during
vulval precursor cell fate patterning in Caenorhabditis elegans. Genetics 188,
847-858. 10.1534/genetics.111.128389.

57

APPENDIX A:
ALIGNMENT OF ARAF, BRAF, CRAF, AND LIN-45

Conserved residues are marked in dark red highlighting. Functionally similar residues are
marked in red font. Secondary structural elements are labeled above the corresponding
sequence. Sequences were aligned using Clustal Omega and structural elements were marked
using ESPript (Robert & Gouet 2014).
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APPENDIX B:
ALIGNMENT OF P97,CDC-48.1, AND CDC-48.2

Conserved residues are marked in dark red highlighting. Functionally similar residues are
marked in red font. Secondary structural elements are labeled above the corresponding
sequence. Sequences were aligned using Clustal Omega and structural elements were marked
using ESPript (Robert & Gouet 2014).
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APPENDIX C:
TABLE OF GENES TESTED USING RNAI
Genes known to interact with UFD-2, LIN-45, or other portions of the ubiquitin-proteasome
system were tested for their ability to stabilize YFP-LIN-45 in the descendants of P6.p.

Tested genes
uba-1
ubc-9
ubc-12
apc-11
fzr-1
fzy-1
lin-23
lin-41
rbx-1
rbx-1/2
rfp-1
wwp-1
cul-1
cyn-4/mog-6
prp-19
hsp-3
hsp-90/daf-21
cdc-48.1
cdc-48.2
cdc-48.1/2
cdc-37
ubq-1
ubq-2

% Stabilized in
P6.p descendants
0/14 (0%)
0/11 (0%)
0/14 (0%)
0/25 (0%)
0/28 (0%)
0/24 (0%)
0/45 (0%)
0/48 (0%)
1/56 (2%)
0/28 (0%)
0/20 (0%)
0/19 (0%)
0/28 (0%)
1/28 (4%)
0/14 (0%)
2/13 (15%)
2/23 (9%)
4/28 (14%)
5/30 (17%)
13/42 (31%)
1/16 (6%)
1/10 (10%)
0/16 (0%)

Justification for testing (pathway or type of
protein)
E1 ubiquitin ligase
E2 ubiquitin ligase
E2 ubiquitin ligase
E3 ubiquitin ligase
E3 ubiquitin ligase
E3 ubiquitin ligase
E3 ubiquitin ligase
E3 ubiquitin ligase
E3 ubiquitin ligase
E3 ubiquitin ligase
E3 ubiquitin ligase
E3 ubiquitin ligase
E3 ubiquitin ligase
U-box E3/E4 ubiquitin ligase (similar to UFD-2)
U-box E3/E4 ubiquitin ligase (similar to UFD-2)
HSP70 family (physically interact with CHIP)
HSP90 family (regulates BRAF)
Protein folding (physically interacts with UFD-2)
Protein folding (physically interacts with UFD-2)
Protein folding (physically interacts with UFD-2)
BRAF regulation pathway
Ubiquitin
Ubiquitin
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